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 Summary 
Members of the Argonaute (Ago) protein family associate with small RNAs and regulate gene 
expression at the level of transcription, mRNA stability or translation. Although a number of small 
RNAs and proteins involved in gene silencing have been identified so far, the spectrum of Ago-
mediated silencing implies an interplay of various additional factors. We therefore purified Ago 
complexes from human cells in order to analyze their protein as well as their RNA content. We 
found that Ago1 and Ago2 reside in three complexes of different sizes, showing distinct Dicer 
and RNA-induced silencing complex (RISC) activities. The smallest complex is formed by 
multiple subcomplexes with distinct enzymatic activities. The two larger complexes form large 
ribonucleoprotein particles (RNPs) carrying a variety of different RNA binding or regulatory 
proteins, providing new insights into the function of Ago proteins. 
The second part of this work focuses on the identification of small RNAs associated with human 
Ago1 and Ago2. Endogenous Ago proteins were purified, followed by small RNA cloning and 
large-scale sequencing. The majority of the cloned RNAs belong to the class of miRNAs. 
Interestingly, individual read numbers suggest preferential Ago binding for at least some 
miRNAs. Besides miRNAs, we found RNA fragments mapping to mRNAs, transposons and 
other non-coding RNAs like tRNAs. Moreover, small RNAs with a length of about 20-22 
nucleotides originating from snoRNAs have been found. The most prominent sequence read 
mapping to snoRNA H/ACA45 is capable of guiding Ago2-mediated cleavage of complementary 
target RNAs. Furthermore, processing of H/ACA45 is Drosha-independent but depending on 
Dicer. Remarkably, the seed sequence of the H/ACA45 processing product is perfectly 
complementary in the 3' UTR of several mRNAs. We could demonstrate that H/ACA45-derived 
small RNAs possess an endogenous mRNA target that is translationally repressed. Together 
with the finding that many snoRNA-derived reads from various deep sequencing libraries are 
conserved in mammals, the data suggest that snoRNA processing is a more general mechanism 
and snoRNA-derived small RNAs can act as miRNAs.  
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1 Introduction 
1.1 RNA silencing, a historical overview 
Less than 2% of the human genome is translated into proteins but far more is transcribed into 
RNA. These non-coding RNAs (ncRNAs) act as important regulators of diverse cellular 
processes. Transfer RNAs (tRNAs) are decoding genetic information into proteins, ribosomal 
RNAs (rRNAs) form part of the ribosome and recognize portions of mRNAs and tRNAs, small 
nuclear RNAs (snRNAs) are involved in splicing and small nucleolar RNAs (snoRNAs) play a 
role in the biogenesis of other RNAs. Moreover, there are classes of ncRNAs downregulating 
gene expression, a phenomena which is also termed RNA silencing. 
RNA silencing was first described in 1990 by Napoli and Jorgensen (Napoli et al., 1990). They 
overexpressed a pigment synthesis enzyme responsible for the deep violet coloration in petunia 
flowers and unexpectedly got white flowers in the end. Because both the transgene and the 
endogenous gene were repressed, this phenomenon was termed “cosuppression”. Two years 
later Romano and Macino described a similar phenomenon in Neurospora crassa where it was 
named “quelling” (Romano and Macino, 1992). In animals, RNA silencing was first documented 
by Guo and Kemphues (Guo and Kemphues, 1995). They found that introduction of both sense 
and antisense RNA resulted in degradation of par-1 mRNA in Caenorhabditis elegans. A major 
breakthrough was achieved in 1998 by Fire and Mello who reported that not single-stranded (ss) 
but double-stranded (ds) RNA was the trigger for gene silencing (Fire et al., 1998). They 
explained that integrated transgenes were responsible for the production of dsRNA in plants and 
fungi and contamination of sense RNA by dsRNA in worms. During the following years it was 
shown in plants and Drosophila extracts that dsRNA is converted into shorter intermediates of 
about 22 nt in length (Hamilton and Baulcombe, 1999; Hammond et al., 2000; Zamore et al., 
2000). These small RNAs, which could induce cleavage of homologous target mRNAs were 
termed small interfering RNAs (siRNAs) and the phenomenon itself RNA interference (RNAi). 
Long dsRNA has not been found to induce RNAi in mammalian cell culture. However, this could 
be explained by the observation that long dsRNA binds and activates the protein kinase R (PKR) 
which in turn activates the interferon pathway, leading to a shut down of protein biosynthesis and 
may result in apoptosis (Kaufman, 1999). The major breakthrough was achieved by Tuschl and 
coworkers who could show that 21 nt siRNA duplexes specifically induce RNAi in mammalian 
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cells (Elbashir et al., 2001). This finding and the potential of RNAi to suppress any gene make it 
particularly attractive for gene therapy approaches (Grimm and Kay, 2007).  
During the time of the discovery of RNA silencing, another class of small RNAs was discovered 
in C. elegans. They were found to be important for the developmental timing of worms and 
therefore called small temporal RNA (stRNA). The first stRNA was described in 1993 by the labs 
of Ambros and Ruvkun (Lee et al., 1993; Wightman et al., 1993). They proposed that the stRNA 
lin-4 regulates lin-14 mRNA by imperfect base pairing in the 3ʼ untranslated region (3ʼ UTR). It 
took another seven years to discover a second stRNA in worms, let-7 (Pasquinelli et al., 2000; 
Reinhart et al., 2000; Slack et al., 2000). Following the discovery of stRNAs, several labs 
identified numerous 22 nt small RNAs from different organisms not only implicated in 
developmental timing (Lagos-Quintana et al., 2001; Lau et al., 2001; Lee and Ambros, 2001; 
Llave et al., 2002). Therefore, the new class of evolutionary conserved RNAs with stRNAs as 
founding members was termed microRNAs (miRNAs). Currently, at least a thousand miRNAs 
are predicted to function in humans and new classes of small RNAs are constantly identified by 
new sequencing technologies. 
Although similar in lengths, no formal connection between siRNAs and miRNAs was made until 
2001 where it was shown that long dsRNA are converted into siRNAs and miRNA precursors 
(pre-miRNAs) into mature miRNAs by the same RNAse III enzyme (Bernstein et al., 2001; 
Grishok et al., 2001; Hutvágner et al., 2001; Ketting et al., 2001; Knight and Bass, 2001). Today 
it is known that both miRNAs and siRNAs share a number of similar proteins for their biogenesis 
and function. 
1.2 Classes of small RNAs in gene silencing 
Small ncRNAs involved in gene silencing are of about 20-30 nt in length and associated with a 
member of the Argonaute (Ago) protein family. Although many classes of small RNAs have been 
discovered, they are divided into three main categories: miRNAs, siRNAs and Piwi-interacting 
RNAs (piRNAs), all of them present in eukaryotes (Carthew and Sontheimer, 2009).  
MiRNAs are involved in the regulation of diverse cellular processes and changes in their 
expression pattern are linked to diseases, in particular cancer (Alvarez-Garcia, 2005; Esquela-
Kerscher and Slack, 2006). They are of about 22 nt in length and are processed from 
endogenously transcribed precursors. Associated with an effector protein, they can lead to 
endonucleolytic cleavage, translational inhibition and/or deadenylation of a target mRNA.  
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Figure 1.1. Overview of small RNAs 
 
Overview of different classes of small RNAs. Many laboratories have identified small RNAs involved in 
gene silencing in different approaches and different organisms. Therefore, the nomenclature of different 
subgroups can vary in the literature. Some groups have several names or are overlapping with other 
groups, as also described in the text. 
 
 
 
SiRNAs are about 21 nt in length and generally lead to endonucleolytic cleavage of perfect 
complementary RNA targets in association with an effector protein. They can be derived from 
long dsRNA from exogenous sources (exo-siRNAs) or from natural sense-antisense pairs (endo-
siRNAs). Depending on their origin and mechanism of action, there are several subgroups of 
endo-siRNAs (Fig. 1.1). Cis-acting RNAs (casiRNAs) are guiding DNA methylation and histone 
modification at their loci of origin. (Chan et al., 2004; Ghildiyal and Zamore, 2009; Hamilton et 
al., 2002; Llave et al., 2002; Mette et al., 2000; Tran et al., 2005; Xie et al., 2004; Zilberman et 
al., 2003). Some of them are also refered to as heterochromatic small RNAs (hcRNAs) or fall 
into a class of repeat-associated RNAs (rasiRNAs) (Farazi et al., 2008). Trans-acting siRNAs 
(tasiRNAs) are generated by the overlap of miRNA and siRNA pathways. (Ghildiyal and Zamore, 
2009; Vazquez et al., 2004). Natural antisense transcript-derived siRNAs (natsiRNAs) originate 
from stress-induced transcription resulting in production of dsRNA and subsequent RNA 
cleavage (Borsani et al., 2005; Ghildiyal and Zamore, 2009; Katiyar-Agarwal et al., 2006). 
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PiRNAs, the third main category of small RNAs involved in gene silencing are primarily found in 
animals. They are restricted to the germ line, where they are important for germ line 
development (Ghildiyal and Zamore, 2009). Their biogenesis and function are still poorly 
understood. In contrast to miRNAs and siRNAs, their precursors are single-stranded and in 
genomic clusters. Moreover, they bind to a different subfamily of effector proteins. A subset of 
rasiRNAs cloned from Drosophila and zebrafish are thought to belong to the piRNA class as they 
are associated with the same protein subfamily. 
1.3 Biogenesis of miRNAs and siRNAs 
Many miRNA loci are in close proximity to each other and transcribed from a polycistronic 
transcription unit. MiRNAs can derive from coding or non-coding genes and from intronic or 
exonic regions (Calin et al., 2002; Rodriguez et al., 2004; Saini et al., 2007). They are generally 
transcribed from RNA polymerase II (Pol II). The transcripts are capped and polyadenylated and 
can be regulated like other Pol II transcripts (Cai et al., 2004; Lee et al., 2004a).  
The stem-loop structured primary miRNA transcripts (pri-miRNAs) are processed in the nucleus 
by proteins that form the so-called microprocessor complex, containing the RNAse III enzyme 
Drosha and its cofactor DGCR8 (Figure 1.2). The transcripts are cleaved at the stem of the 
hairpin structure releasing a 70 nt long miRNA precursor (pre-miRNA) (Lee et al., 2003). 
Cleavage products have a 5ʼ phosphate and a 2 nt 3ʼ overhang, characteristic for RNAse III 
cleavage. However, this is not the only way to generate pre-miRNAs. An alternative pathway 
exists for miRNAs residing in introns that precisely have the size and feature of a pre-miRNA 
(Figure 1.2). The small RNAs derived from short intronic hairpins are called mirtrons and their 
precursors are directly liberated by splicing (Berezikov et al., 2007; Okamura et al., 2007; Ruby 
et al., 2007). Some mirtrons contain 5ʼ or 3ʼ tails and might require exonucleolytic trimming 
besides splicing.  
After the first processing step, pre-miRNAs are exported into the cytoplasm by Exportin-5, a 
member of the nuclear export receptor family first identified as export factor for tRNAs 
(Bohnsack et al., 2004; Calado et al., 2002; Lund et al., 2004; Yi et al., 2005). Nuclear binding of 
a pre-miRNA by Exportin-5 requires the GTP-bound form of the cofactor Ran and releases its 
cargo in the cytoplasm upon hydrolysis of Ran-GTP to Ran-GDP. In the cytoplasm, pre-miRNAs 
are processed by the RNAse III enzyme Dicer and its partners TRBP and probably PACT into 
small dsRNA of about 22 nt in length with a 5ʼ phosphate and a 2 nt 3ʼ overhang (Figure 1.2), 
(Bernstein et al., 2001; Chendrimada et al., 2005; Grishok et al., 2001; Haase et al., 2005; 
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Hutvágner et al., 2001; Ketting et al., 2001; Knight and Bass, 2001; Lee et al., 2006). The small 
RNA duplex gives rise to a mature miRNA sequence whereas the opposing strand, the so-called 
miRNA* sequence, is thought to be degraded. The mature miRNAs is incorporated into protein 
complexes and guide them to specific mRNAs target sites. Perfect complementarity between the 
small RNA and its target lead endonucleolytic mRNA cleavage whereas imperfect base-pairing 
induces translational inhibition and/or deadenylation (Fig. 1.2).  
MiRNAs and siRNAs both associate with the same effector proteins and show similarities in their 
processing pathways. However, in contrast to miRNAs, siRNA are processed independent of 
Drosha from long dsRNA from exogenous sources or natural sense-antisense pairs, (Fig. 1.2). 
Depending on the organism, exogenous siRNAs can be derived by cleavage of viral RNAs, by 
introducing long, perfectly base-paired dsRNA into the cytoplasm or by direct uptake from the 
environment. (Mello and Conte, 2004). In plants and worms, siRNAs do not need to be double-
stranded because of the help of the RNA-dependent RNA polymerase (RdRP). In contrast to 
typical RNA polymerases they use RNA templates instead of DNA. In plants, RdRPs use mRNA 
fragments previously cleaved by primary siRNAs as template to synthesize long dsRNA (Fig. 
1.2, Box). The newly synthesized dsRNA can then be further processed into secondary siRNAs 
(Bouché et al., 2006; Deleris et al., 2006; Fusaro et al., 2006; Ghildiyal and Zamore, 2009; 
Vaistij et al., 2002; Xie et al., 2004). There is slightly different mechanism in worms: primary 
siRNAs are directly guided to the mRNA target; however, this does not induce mRNA cleavage 
but leads to the recruitment of RdRP and subsequent synthesis of secondary siRNAs (Fig. 1.2, 
Box). In contrast to plant secondary siRNAs, they have a 5ʼ diphosphate or triphosphate, 
indicating that they are produced by transcription rather than by Dicer cleavage (Aoki et al., 
2007; Ghildiyal and Zamore, 2009; Pak and Fire, 2007; Sijen et al., 2001; Sijen et al., 2007; 
Smardon et al., 2000).  
Besides exo-siRNAs there are also endo-siRNAs, first discovered in plants and C. elegans 
(Ambros et al., 2003b; Hamilton et al., 2002; Mello and Conte, 2004; Zilberman et al., 2003). The 
production of endo-siRNAs often involves RdRP activity. However, endo-siRNAs have recently 
been found in animals such as flies and mice, where a gene encoding for RdRP is absent. 
These endo-siRNAs are derived from transposable elements, natural antisense transcripts, long 
intermolecular paired hairpins and pseudogenes. (Chung et al., 2008; Czech et al., 2008; 
Ghildiyal et al., 2008; Kawamura et al., 2008; Okamura et al., 2008a; Okamura et al., 2008b; 
Yang and Kazazian, 2006). 
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Figure 1.2. Overview of the biogenesis pathway of miRNAs and siRNAs 
 
 
 
 
On the left, an overview of the miRNA and siRNA pathway is shown. The box on the right shows amplified 
silencing in plants and in worms. A detailed description of these processes is found in the text, chapter 
1.3, Biogenesis of miRNA and siRNAs. Sec. Ago means Ago protein with secondary siRNAs. 
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1.3.1 The RNAse III enzymes Drosha and Dicer 
Two RNAse III enzymes are involved in small RNA maturation: Drosha and Dicer. RNAse III 
enzymes are grouped into three classes. Bacterial and yeast RNAse III proteins belong to class 
I, having one RNAse III domain (RIIID) and a double-stranded RNA binding domain (dsRBD). 
Drosha is a prominent member of class II, with two RIIIDs and a dsRBD, whereas Dicer belongs 
to class III possessing additional domains such as an N-terminal DExD/H-box helicase domain, 
a domain of unknown function (DUF) and a PAZ domain (MacRae and Doudna, 2007).  
Drosha is a protein of about 130-160 kDa, only found in animals. It functions as monomer 
forming an intramolecular dimer structure with its two RNAse III domains, recognizing the 3ʼ and 
5ʼ end of the pri-miRNA stem (Han et al., 2006; Han et al., 2004). Drosha cleavage generates 5ʼ 
phosphates and 2 nt 3ʼ overhangs which are recognized efficiently by Exportin-5 and Dicer. As 
its dsRBD is not sufficient for substrate binding Drosha alone can not cleave pri-miRNAs but 
needs its partner DGCR8, also known as Pasha (partner of Drosha) in C. elegans and D. 
melanogaster. DGCR8 interacts with Drosha through its C-terminal domain forming a complex 
called the microprocessor complex. DGCR8 is about 120 kDa in size, contains two dsRBDs 
recognizing dsRNA-ssRNA junctions and can position the ribonuclease domain of Drosha eleven 
nt away from the junction (Han et al., 2006). DGCR8 also interacts with the about 33 bp long 
stem and the terminal loop of the pri-miRNA. Therefore DGCR8 is responsible for substrate 
recognition and determines the correct cleavage position for Drosha. Moreover, it enhances the 
stability of its partner Drosha. In turn, DGCR8 is negatively regulated by the microprocessor 
complex itself through mRNA cleavage in the 5ʼ untranslated region and the coding sequence. 
As a consequence, the expression of DGCR8 is reduced when sufficient microprocessor activity 
is available (Han et al., 2009). Besides the cross-regulation of Drosha and DGCR8, 
microprocessor-mediated cleavage can also be regulated by miRNA-specific mechanisms. 
Some miRNAs need the interaction of the two DEAD-box RNA helicases p72 and p68 (DDX5) to 
interact with the microprocessor complex for efficient processing, pri-miR-18a is bound 
specifically by hnRNP A1 to facilitate Drosha cleavage and TGF-β signaling enhances Drosha 
processing by inducing SMAD binding to pri-miR-21 (Davis et al., 2008; Fukuda et al., 2007; Guil 
and Cáceres, 2007; Winter et al., 2009). A more recent study shows that p53 enhances the 
maturation of several miRNAs with growth suppressive functions by interacting with the RNA 
helicase p68 (DDX5) (Suzuki et al., 2009). 
Drosha cleavage occurs co-transcriptionally, in both independently transcribed miRNA genes 
and intron-encoded miRNAs. Moreover, it is suggested that Drosha processing might take place 
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after recruiting the early spliceosome complex but before splicing (Ballarino et al., 2009; Kim and 
Kim, 2007; Morlando et al., 2008; Pawlicki and Steitz, 2008). 
Following nuclear processing, pre-miRNAs are exported to the cytoplasm and further processed 
by Dicer. In contrast to Drosha, Dicer does not need a stem with a large terminal loop and 
flanking sequences but basically cleaves any dsRNA with preferably a 2 nt 3ʼ overhang 
terminus. With this feature, not surprisingly, Dicer is involved in both miRNA and siRNA 
maturation. Human Dicer is a protein of about 220 kDa and highly conserved throughout 
eukaryotes, except S. cerevisiae. Mammals and C. elegans have only one Dicer whereas other 
organisms encode for several Dicer homologues with distinct roles. In plants, where Drosha is 
not expressed, Dicer-like (Dcl) protein 1 is responsible for processing both the long primary 
miRNA and the precursor miRNA. Dcl-2, 3 and 4 are involved in different siRNA pathways. In 
Drosophila, where two Dicer forms exist, Dicer-1 is required for miRNA biogenesis and Dicer-2 
for processing of dsRNA into siRNA (Lee et al., 2004b). 
Like Drosha, human Dicer has two RNAse III domains and one C-terminal dsRBD. In addition, 
there is also a domain of unknown function (DUF283), a PAZ domain and a N-terminal 
ATPase/DEXD helicase domain. Interestingly, dsRNA processing by Dcr-2 in Drosophila and 
Dcr-1 in C. elegans is stimulated by ATP whereas human Dicer appears to cleave dsRNA 
without requirement of ATP (Bernstein et al., 2001; Ketting et al., 2001; Liu et al., 2003; Nykänen 
et al., 2001; Zhang et al., 2002). Dicers of G. intestinalis, Dictyostelium discoideum, and T. 
brucei are even devoid of the helicase/ATPase domain (Macrae et al., 2006; Martens et al., 
2002; Shi et al., 2006). In general, Dicers of lower eukaryotes frequently have a less complex 
domain organization. While bacterial Dicer works as a homodimer, human Dicer works as an 
intramolecular dimer with its two RNAse III domains. The processing center lies within the active 
site of the two RNAse III domains. Each of them cleaves one of the two strands, generating ends 
with a 5ʼ phosphate and a 2 nt 3ʼ overhang (Zhang et al., 2004). The α-helical region between 
the PAZ and the RNAse III domain serves as a “ruler” measuring the length of the excised RNA 
fragment. The PAZ domain preferentially recognizes 2 nt 3ʼ protruding ends. However, blocking 
the ends of dsRNA with RNA tetraloops or DNA–RNA duplexes revealed that free ends are not 
absolutely required: the terminally blocked dsRNA is cleaved internally, with reduced kinetics. 
After the initial internal cleavage, normal kinetics is restored as 2-nt 3′-overhang-containing ends 
become available (Zhang et al., 2004).  
Although Dicer on its own can mediate cleavage of dsRNA or pre-miRNAs, it associates with 
dsRNA binding proteins. Human Dicer associates with TRBP (Tar RNA binding protein) and/or 
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PACT (protein activator of PKR), which is almost 50% similar to TRBP (Chendrimada et al., 
2005; Haase et al., 2005; Lee et al., 2006). Both seem not to be required for Dicer cleavage but 
contribute to the formation of the small RNA effector complexes. In Drosophila, Dicer-1 requires 
Loquatious (Loqs) for pre-miRNA processing and Dicer-2 R2D2 (Förstemann et al., 2005; Liu et 
al., 2003; Saito et al., 2005). Drosophila Dicer-2 plays a role in both endo- and exo-siRNAs. 
However, depletion of its partner protein R2D2 has almost no effect on endo-siRNAs. They 
seem to depend on an isoform of Loqs, usually known to be the partner of Dicer-1 in the miRNA 
pathway (Hartig et al., 2009; Zhou et al., 2009). In plants, miRNAs, viral siRNAs, transgene 
siRNAs and tasiRNAs are processed by Dcl-1-4 and their different cofactors, for example 
different members of the HYL1 family (Margis et al., 2006). These finding suggest that different 
categories of siRNAs may require different Dicers and different binding partners. 
Besides its role in siRNA and miRNA maturation, Dicer is suggested do be involved in 
mammalian development. Dicer-deficient mice die early in development (E7.5). Dicer deficient 
embryonic stem cells (ES cells) show significant proliferation and differentiation defects. They 
are unable to process pre-miRNAs or dsRNAs but are still able to perform siRNA-mediated gene 
silencing (Bernstein et al., 2003; Kanellopoulou et al., 2005; Murchison et al., 2005). The severe 
consequences upon Dicer depletions are probably due to the loss of miRNAs. However, DGCR8 
depleted cells show a less severe phenotype. DGCR8 knockout embryos arrest early in 
development and knockout ES cells are defective in differentiation but unlike Dicer knockout 
cells, they do not fully downregulate pluripotency markers, retain the ability to produce ES cell 
colonies and even do express some markers in differentiation. This could be explained by the 
fact that a few DGCR8 independent miRNAs are still functioning in the knockout cells. An 
analysis of DGCR8 depleted cells revealed that four canonical miRNAs, several mirtrons and 
other miRNA-like sequences are still present (Babiarz et al., 2008). However, the more severe 
phenotype in Dicer deficient cells could also indicate that Dicer in addition has miRNA-
independent roles in ES cell functions (Wang et al., 2007).  
1.3.2 Argonaute proteins 
After Dicer cleavage, the miRNA or siRNA is loaded into an effector complex containing an 
Argonaute protein as the core component. Ago proteins were named after the AGO1 knockout 
phenotype in Arabidopsis thaliana, resembling the tentacles of the octopus Argonauta argo 
(Bohmert et al., 1998). Based on sequence homology, Argonaute proteins can be divided into 
two subclasses: one resembling Arabidopsis AGO1 and the other related to Drosophila Piwi. 
The Ago subclass in humans consisting of hsAgo1-4 is ubiquitously expressed and associates 
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with miRNAs and siRNAs. The Piwi members are mainly restricted to the germ line, associating 
with piRNAs. The human genome encodes four Piwi proteins named Piwil1 (Hiwi), Piwil2 (Hili), 
Piwil3 and Piwil4 (Hiwi2) (Sasaki et al., 2003). Recently, a third subclass has been identified, 
named group 3. It is worm-specific and mainly contains Ago proteins lacking endonucleolytic 
activity (Tolia and Joshua-Tor, 2007).  
Ago proteins are conserved throughout species and many organisms encode for multiple 
members, ranging from one in S. pombe, five in Drosophila, eight in humans, ten in Arabidopsis 
up to 27 in C. elegans. They have a molecular weight of about 100 kDa and can also be called 
PPD proteins because of their two signature domains, the PAZ domain (Piwi/Argonaute/Zwille) 
and the PIWI domain. Ago proteins are also found in some prokaryotes, but their function in 
these organisms remains unclear. However, crystallographic studies of archaeal Pyrococcus 
furiosus and eubacterial Aquifex aeolicus Ago brought more insight into structure and function of 
these proteins (Ma et al., 2004; Parker et al., 2004; Rashid et al., 2007; Song et al., 2004; Yuan 
et al., 2005). It was found that the PIWI domain resembles the structure of bacterial RNAse H 
which can cleave an RNA strand in a RNA/DNA hybrid (Keck et al., 1998). Later it was 
discovered that the catalytic activity of miRNA effector complexes, also termed Slicer, resides in 
the Argonaute protein itself. Interestingly, not all Argonaute proteins show endonucleolytic 
activity. In humans, only Ago 2 has been shown to cleave the phosphodiester bond of a target 
RNA opposite of nt 10 and 11 of the siRNA although the conserved sequence motif DDH 
important for divalent metal ion binding and catalytic activity is present in other human Ago 
proteins as well (Liu et al., 2004; Meister et al., 2004; Rivas et al., 2005). More recently, the 
structural studies have been extended to eubacterial Thermus thermophilus Argonaute 
containing a guide strand only or a guide DNA strand and a target RNA duplex (Wang et al., 
2008b; Wang et al., 2009; Wang et al., 2008c). The structure is divided into two lobes. One lobe 
contains the PAZ domain with the N-terminal domain connected through a linker region L1. The 
second lobe consists of the middle domain (mid domain) and the PIWI domain. The PAZ 
domain, shared with Dicer enzymes, forms a specific binding pocket for the 3ʼ protruding end of 
the RNA or DNA in case of Thermus thermophilus in a sequence independent manner (Lingel et 
al., 2003; Ma et al., 2004; Song et al., 2003). The 5ʼ phosphate is positioned in a specific binding 
pocket in the mid domain (Ma et al., 2005; Parker et al., 2005). The protein-DNA contacts are 
dominated by sugar-phosphate backbone interactions, as expected for a protein that can 
accommodate a wide range of guide sequences. The target RNA is base pairing with the guide 
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DNA at least in the seed sequence, a region especially important for target recognition, but is not 
touching the protein (Wang et al., 2008b; Wang et al., 2009; Wang et al., 2008c)}.  
1.4 MiRNA and siRNA effector complexes 
To perform their effector functions, miRNAs and siRNAs are incorporated into Argonaute 
proteins which are the key components of ribonucleoprotein complexes (miRNPs), often referred 
to as RNA induced silencing complex (RISC). During RISC assembly, the RNA duplex must be 
unwound into individual strands. One strand, called guide strand or mature miRNA, remains 
associated with the Argonaute protein. The opposing strand, called passenger strand or miRNA* 
is thought to be degraded. Strand selection for siRNAs follows the asymmetry rules, meaning the 
strand with its 5ʼ terminus at the thermodynamically less stable end becomes part of the active 
RISC (Tomari et al., 2004b). For miRNAs these rules seem to work only to a certain extent as 
some duplexes produce mature miRNAs from both strands (Khvorova et al., 2003; Wei et al., 
2009). Currently, it is not known how small RNA duplexes are separated into two single strands. 
It was shown that the passenger strand can be cleaved by Drosophila Ago proteins and hAgo2 
(Leuschner et al., 2006; Matranga et al., 2005; Miyoshi et al., 2005; Rand et al., 2005). However, 
this is only possible for perfect complementary duplexes loaded in Ago2. It is not known how 
miRNA duplexes that are usually not perfectly complementary at the Ago2 cleavage site are 
unwound and how cleavage-incompetent Ago proteins are loaded. In this case, a helicase might 
contribute to duplex unwinding but is probably not generally required as RISC loading of miRNAs 
was shown to be ATP independent (Maniataki and Mourelatos, 2005). In contrast, a recent study 
shows that Drosophila Ago1 RISC loading is ATP dependent but duplex unwinding is a passive 
process that does neither need Slicer activity nor ATP (Kawamata et al., 2009). 
In humans, RISC assembly is not well understood. The RISC assembly complex consists of 
Dicer, its dsRBD protein partner TRBP (and/or PACT) and an Argonaute protein (Chendrimada 
et al., 2005; Haase et al., 2005; Lee et al., 2006). This trimeric complex is able to load a mature 
miRNA according to the asymmetry rules and cleave a complementary target mRNA (Gregory et 
al., 2005; Maniataki and Mourelatos, 2005). However, the data that Dicer deficient ES cells are 
unable to process pre-miRNAs or dsRNAs but are still able to perform siRNA-mediated gene 
silencing indicate that mammalian Dicer may not play a major role in RISC formation 
(Kanellopoulou et al., 2005; Murchison et al., 2005). This is consistent with a recent study in 
Drosophila where Dcr-1 seems to be dispensable for Ago1-RISC loading (Kawamata et al., 
2009). In contrast, Dcr-2 and R2D2 both seem to be involved in RISC loading and sensing 
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thermodynamic asymmetry of the siRNA duplex. R2D2 binds the duplex with orientation to the 
thermodynamic more stable 5ʼ end and is therefore critical for strand selection (Tomari et al., 
2004b). Although Dicer alone can process dsRNA into siRNAs, RISC assembly is dependent on 
both Dicer-2 and R2D2, suggesting that RISC loading is separable from siRNA production (Liu et 
al., 2003; Liu et al., 2006; Matranga et al., 2005; Tomari et al., 2004b). Indeed, it was shown that 
both Dcr-2 and R2D2 can act in vivo to load Ago2 with miR-277, a miRNA produced by Dcr-1 
and Loqs. It could be possible that the RNA duplexes are released after processing by Dicer and 
then rebound by Dcr-1/Loqs or Dcr-2/R2D2 complexes, the Ago1- or Ago2 loading machinery, 
respectively (Förstemann et al., 2007; Tomari et al., 2007). This could also explain that miRNA 
and miRNA* both can be incorporated into mature RISC.  
Ever since the first miRNAs and siRNAs were discovered, a lot of investigations on the protein 
machinery have been done by analyzing where siRNA mediated cleavage activity is residing. 
Several RISC components have been found that differ in size and protein composition. Besides 
Argonaute proteins three additional proteins have been identified in Drosophila RISC: Vasa 
intronic gene (VIG) protein, Tudor SN and fragile X related protein (dFXR) (Caudy et al., 2003; 
Caudy et al., 2002). Moreover dFXR-miRNA complexes including the RNA helicase Dmp68 and 
the ribosomal proteins L5 and L11 have been found (Ishizuka et al., 2002). In humans, the 
homolog of dFXR, FMRP (fragile X mental retardation protein) has also been identified. 
Moreover, miRNAs and Ago2 were found in a 15S complex containing Gemin 3 and Gemin 4 
(Mourelatos et al., 2002). A proteomic analysis of human Ago1 and Ago2 complexes revealed 
the Arginine methyltransferase PRMT5 and the putative DEAxD-box helicase Mov10. MOV10 is 
a candidate ortholog of the plant protein SDE- 3 and the Drosophila protein Armitage, both of 
which are involved in RNAi (Dalmay et al., 2001; Tomari et al., 2004a). Genetic screens in C. 
elegans, RNAi screens in D. melanogaster, and biochemical purifications of Argonaute 
complexes in human cells showed interaction of GW182 protein family with Argonaute proteins 
(Ding et al., 2005; Eulalio et al., 2008b; Jakymiw et al., 2005; Liu et al., 2005; Meister et al., 
2005; Rehwinkel et al., 2005). GW182 is termed after its molecular weight and the presence of 
glycine and tryptophan repeats and was shown to be localized in processing bodies (p-bodies) 
or GW bodies, cytoplasmic regions enriched with proteins involved in mRNA turnover 
(Eystathioy et al., 2002; Eystathioy et al., 2003). Insects have one GW182 protein, C. elegans 
have two (AIN1 and AIN2) and humans three paralogs (TNRC6A/GW182, TNRC6B and 
TNRC6C) (Eulalio et al., 2009a). In Drosophila, depletion of GW182 leads to upregulation of 
miRNA targets (Behm-Ansmant et al., 2006a; Eulalio et al., 2009a; Eulalio et al., 2008b; Eulalio 
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et al., 2009b; Eulalio et al., 2009c; Rehwinkel et al., 2005). Moreover, tethering of GW182 to the 
mRNA represses translation independently of Drosophila Ago1, demonstrating that it is an 
important effector protein functioning more downstream of Ago functioning in gene silencing 
(Behm-Ansmant et al., 2006a).  
1.5 Regulation of gene expression by miRNAs and siRNAs 
MiRNAs and siRNAs guide RNA silencing effector complexes containing an Ago protein to their 
target mRNA. A key determinant of the regulatory mechanism of RNA silencing is the degree of 
complementarity between the small RNA and the target RNA. Perfect complementarity promotes 
Ago2-mediated endonucleolytic cleavage whereas mismatches in the central region of the small 
RNA lead to repression of mRNA translation (Doench et al., 2003).  
1.5.1 Translational repression 
The mechanism of translational repression by miRNAs is still an ongoing debate. Studies were 
carried out in different laboratories with different experimental approaches leading to various 
results. Several models are under discussion, such as inhibition of translation at initiation steps 
or at post initiation steps, including co-translational protein degradation or ribosome drop-off.  
1.5.1.1 Inhibition of translation at initiation steps 
mRNA translation starts with the recognition of the 5ʼ-terminal cap by the eIF4E subunit of the 
eukaryotic translation initiation factor (eIF) eIF4F, also containing eIF4A and eIF4G. Interaction 
of eIF4F with eIF3 leads to the recruitment of the 40S ribosomal subunit, which starts scanning 
the 5ʼ UTR of the mRNA. After joining of the 60S subunit, translation begins at the start codon. 
Translational efficiency is stimulated by circularization of the mRNA. This interaction is mediated 
by interaction of eIF4G with the poly(A)-binding protein 1 (PABP1) associated with the poly(A) 
tail. Some mRNAs can initiate translation cap-independent and without or only a few initiation 
factors due to the presence of an internal ribosome entry site (IRES) (Filipowicz et al., 2008).  
Several laboratories provided support that miRNA-mediated repression occurs at early steps of 
translation. In Drosophila and mouse Krebs2 ascite cells, miRNAs inhibited the association with 
either the small ribosomal subunit or 80S ribosome (Mathonnet et al., 2007; Thermann and 
Hentze, 2007). Based on density gradient fractions it was shown that mRNAs repressed by 
miRNAs are not sedimenting in polysome fractions but shift to the free mRNP pool (Pillai et al., 
2005). Furthermore, it was shown that mRNAs containing binding sites for miRNAs can be 
repressed if they contain a functional m7G cap but not if they only contain an IRES or a non-
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functional cap (Humphreys et al., 2005; Mathonnet et al., 2007; Pillai et al., 2005; Wakiyama et 
al., 2007). Cap dependency was also shown by experiments with bicistronic constructs. Only the 
activity of the first cap-dependent cistron was repressed by the endogenous let7 miRNA but not 
the downstream cistron driven by the initiation factors eIF4E or eIF4G directly tethered at the 
intercistronic region (Pillai et al., 2005).  
Supporting the role of the cap in translational repression is a study showing that providing the 
cap-binding complex to a cell free system can relieve miRNA-mediated repression (Mathonnet et 
al., 2007). These observations can be explained by a model that Ago contains a cap-binding 
motif and can compete with eIF4E for m7G binding (Kiriakidou et al., 2007). A study in 
Drosophila agrees with the importance of the described Ago motif, however, explains that it is 
not important for cap binding but rather for interaction with GW182, a protein important for 
translational repression and deadenylation (Eulalio et al., 2008b).  
A second model shows that Ago2 can recruit the eukaryotic initiation factor eIF6, thereby 
blocking the association of the ribosomal subunits and causing translational repression. EIF6 is 
involved in 60S ribosomal subunit biogenesis and prevents its premature association with the 
40S subunit. It was shown that depletion of eIF6 in human cells and C. elegans rescues mRNA 
targets from inhibition (Chendrimada et al., 2007). Moreover, miRNA-targeted mRNAs in 
reticulocyte lysate become enriched for 40S but not 60S ribosomal units (Wang et al., 2008a). 
However, studies in Drosophila, where depletion of eIF6 has no or little effect on miRNA 
silencing are contradicting the involvement of eIF6 in the mechanism of repression (Eulalio et al., 
2008a). 
Other studies were performed to analyze the poly(A) tail requirement. In reticulocyte lysate and 
human cells translational repression occurred only when target mRNAs contained both a cap 
and poly(A)tail (Wakiyama et al., 2007; Wang et al., 2006). In HEK293 lysate mRNAs containing 
miRNA binding sites underwent deadenylation no matter whether they contained a m7G cap, a 
cap analogue or whether translation was IRES mediated (Wakiyama et al., 2007). These data 
support a model that translation is repressed because the cap and the deadenylated tail cannot 
interact through proteins, preventing circularization of the mRNA needed for stimulation of 
translation. Contradicting to this model are studies where mRNA transcripts lacking a poly(A) tail 
can still undergo miRNA mediated repression (Humphreys et al., 2005; Pillai et al., 2005; Wu et 
al., 2006). 
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1.5.1.2 Inhibition of translation at post-initiation steps 
In contrast to these studies, data in C. elegans suggest a mechanism of miRNA repression after 
initiation of translation by showing that target mRNAs of lin-4 miRNA remain associated with 
polysomes (Olsen and Ambros, 1999; Petersen et al., 2006; Seggerson et al., 2002). Incubation 
of active translating polysomes with translational inhibitors led to ribosome dissociation and 
shifted miRNAs to lighter gradient fractions, suggesting that miRNPs may physically associate 
with polyribosomes (Maroney et al., 2006; Nottrott et al., 2006; Petersen et al., 2006). Other 
studies with bicistronic constructs showed that the second cistron under control of an IRES can 
be repressed (Lytle et al., 2007; Petersen et al., 2006).  
Based on these observations two models have been proposed. One model suggested that 
miRNAs cause premature ribosome dissociation or ribosome drop-off (Petersen et al., 2006). 
The other proposes that the nascent polypeptide chain might be degraded co-translationally. 
However, polypeptide chains could not be detected (Nottrott et al., 2006; Petersen et al., 2006). 
Moreover, translational repression was not inhibited when reporter proteins were directly 
targeted to the endoplasmatic reticulum (ER) to exclude the possibility that nascent proteins are 
degraded in the cytosol (Pillai et al., 2005). 
1.5.1.3 Inhibition of translation: initiation versus post-initiation steps 
So far, it is difficult to propose a unified model of how miRNAs inhibit translation. The 
discrepancies in the current data are not easy to explain. Cosedimentation of miRNPs with 
polysomes does not necessarily indicate post-initiation repression but might simply reflect the 
association of miRNPs with mRNAs undergoing productive translation. Also, binding of miRNPs 
to the 3ʼ UTR in Drosophila extracts was shown to induce formation of pseudo-polysomes. 
These mRNP aggregates similar to polysomes were observed even in the absence of 
translation, suggesting that in some studies polysomes might have been misinterpreted 
(Thermann and Hentze, 2007). However, there are no simple technical or experimental 
explanations to explain all the different data obtained. It is possible that some data could be 
secondary effects of miRNA-mediated silencing but it is rather likely that miRNAs are able to 
mediate translational inhibitions in different ways. For a more comperehensive understanding of 
the underlying mechanisms, further studies will be required. 
1.5.1.4 MiRNA-mediated deadenylation and destabilization of target mRNAs 
Recently, it has been demonstrated that miRNAs can not only guide translational repression but 
also destabilization of target mRNAs (Bagga et al., 2005; Behm-Ansmant et al., 2006a; 
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Chendrimada et al., 2007; Eulalio et al., 2007; Giraldez et al., 2006; Wu et al., 2006). It was 
shown that mRNA targets for overexpressed miRNAs become less abundant and 
overexpression of miR-430 in zebrafish correlates with degradation of several maternal mRNAs 
containing miR-430 binding sites (Giraldez et al., 2006; Lim et al., 2005). Furthermore, 
downregulation of miRNA pathway components such as Dicer and Ago proteins lead to an 
increase of predicted miRNA targets (Behm-Ansmant et al., 2006b; Eulalio et al., 2007; Giraldez 
et al., 2006; Rehwinkel et al., 2006; Schmitter et al., 2006). In animals, RNA decay by miRNAs is 
mediated by the general mRNA degradation machinery initiated by deadenylation and decapping 
rather then through endonucleolytic cleavage - unless the miRNA is fully complementary to its 
target RNA as in the case of miR-196 and its target HoxB8 in mice (Behm-Ansmant et al., 
2006b; Eulalio et al., 2007; Giraldez et al., 2006; Wu et al., 2006; Yekta et al., 2004). 
The mechanism of miRNA-mediated decay but not translational repression requires proteins of 
the mRNA degradation machinery such as the CCR4-NOT deadenylase complex, the decapping 
enzyme DCP2 and several decapping activators including DCP1, Ge-1, EDC3 and RCK/p54. 
Furthermore, it depends on a member of the Ago and GW182 protein family (Behm-Ansmant et 
al., 2006a; Eulalio et al., 2007). A recent study in mouse Krebs-2 ascites extractes gives more 
insight into the mechanism by which GW182 is involved in silencing and how translational 
repression and mRNA decay contribute to silencing (Fabian et al., 2009). Consistently with 
previous data, it is observed that miRNA-mediated deadenylation requires a GW182 ortholog 
and the CCR-NOT deadenylase complex containing CAF1. Since miRNA loaded RISC complex 
is known to interact with the poly(A)-binding protein PABP and CAF1, it is shown that CAF1 is at 
least partially responsible for miRNA-mediated deadenylation and PABP-GW182 interaction is 
required to facilitate the process (Landthaler et al., 2008); (Fabian et al., 2009). PABP-eIF4G 
binding seems to interfere with miRNA-mediated deadenylation and it is possible that GW182 
may compete with eIF4G in PABP binding. Furthermore, Fabian and collegues show that 
miRNA-mediated deadenylation is detected 1.3h after incubating a reporter construct in Krebs 
extract whereas inhibition of cap-dependent translation is detected within the first hour. However, 
repression further increases after longer incubation time and is partially inhibited in CAF-1 
depleted extract. This could explain the results obtained in a different study in mammalian cells 
where it is shown that let-7 reporter constructs are deadenylated preceding measurable 
translational repression and that blocking deadenylation partially impairs translational repression 
(Beilharz et al., 2009). Taken together, these data suggest that miRNA-mediated deadenylation 
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can contribute to translational repression and mRNA decay but might also have additional 
repressive effects in addition to the initial inhibition of translation.  
1.5.2 Other miRNA functions (miRNAs activating gene expression) 
Recent data showed that a reporter mRNA containing the tumor necrosis factor α (TNFα) AU-
rich element (ARE) has a miRNA binding site. AREs are highly conserved 3'UTR sequences that 
can stimulate mRNA decay mediated by ARE-binding proteins such as TTP, AUF-1 or BRF1 or 
regulate mRNA translation with the help of HuR or TIA-1 (Bhattacharyya and Filipowicz, 2007). 
Binding of a miR-369 to the reporter mRNA containing TNFαARE can stimulate translation in G1 
arrested cells whereas no stimulation occurs if the miRNA is absent. However, miR-369 
represses translation during other cell cycle phases. Under repressing conditions, Ago2 was not 
associated to FXR1 but under conditions inducing translational stimulation, both Ago2 and FXR1 
were present and essential for upregulation to occur (Vasudevan and Steitz, 2007; Vasudevan et 
al., 2007). However, they both have been found to mediate translational repression in earlier 
studies.  
A first positive regulatory function for a miRNA has been reported in liver cells, where miR-122 
has stimulatory effects on the replication of Hepatitis C Virus by binding directly to a site in the 
5'-UTR of the viral RNA. miR-122 increases the association with ribosomes with HCV RNA, 
leading to translational stimulation whereas miR-122 complementary sequences in the 3ʼ UTR 
have no effects on translation (Henke et al., 2008). However, it is shown by another group that 
placing the site into the 3ʼ UTR leads to translational repression. The authors suggested, the 
location of the miR-122-binding site dictates its effect on gene expression (Jopling et al., 2008). 
Similarly, more recent data showed that interaction of miR-10a interact with the 5ʼ UTR of certain 
ribosomal subunits leading to their activated translation, whereas interaction with the 3ʼ UTR 
leads to repression (Ørom et al., 2008). However, other studies showed that miRNA interacting 
with the 5ʼ UTR can also repress translation (Lytle et al., 2007).  
In a different study it was shown that miRNAs targeting promoter sequences can induce gene 
expression. The gene promoter of E-cadherin has a putative target site for miR-373. Both miR-
373 and its precursor hairpin can induce expression of the candidate in a Dicer dependent way 
(Place et al., 2008). However, this is not a general mechanism as different data showed that 
miR-320 targeting the promoter of POLR3D seems to have a repressive function (Kim et al., 
2008). Interestingly, promoter associated small RNAs seem not to be rare but their function 
needs to be investigated (Janowski et al., 2005; Janowski et al., 2006; Kapranov et al., 2007; 
Schwartz et al., 2008; Taft et al., 2009a). 
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Taken together, examples for miRNAs activating gene expression are quite rare and more 
comprehensive analysis needs to be done to observe if this can be a more general mechanism 
of miRNAs. In theses further studies it is important to consider the whole context of the cell and 
take into account different cell cycle stages and the influence on different regulatory elements on 
a single mRNA to study miRNA mechanisms. 
1.5.3 Transcriptional gene silencing 
Transcriptional gene silencing was first discovered in plants by the discovery that small RNAs 
derived from transgenes and viral RNAs could guide methylation of homologous DNA 
sequences (Hamilton and Baulcombe, 1999; Mette et al., 2000; Wassenegger et al., 1994). 
Further studies showed that DNA methylation of a specific transgene is Dicer and Ago 
dependent and linked to histone H3 lysine 9 (H3K9) methylation (Henderson et al., 2006; 
Lippman and Martienssen, 2004; Zilberman et al., 2003). In contrast to plants, fission yeast can 
only induce histone methylation. In S. pombe, deletion of the single Ago, Dicer or RdRP protein 
result in loss of heterochromatin gene silencing, reduced H3K9 methylation at centromeric 
repeats and accumulation of ncRNAs transcribed from centromeric repeats and processed into 
siRNAs (Reinhart and Bartel, 2002; Volpe et al., 2003). The Ago1 containing effector complex in 
S. pombe is termed RNA-induced transcriptional silencing complex (RITS) (Cam et al., 2005; 
Verdel et al., 2004). RITS associates with nascent transcripts and RNA polymerase. A histone 
methyltransferase leads to H3K9 methylation, the recruitment of the chromodomain-containing 
protein Swi6 and to subsequent heterochromatin formation (Bühler et al., 2006; Djupedal et al., 
2005; Kato et al., 2005; Lippman and Martienssen, 2004). Furthermore, RITS interacts with the 
RdRP to reinforce and spread silencing (Sugiyama et al., 2005).  
In mammals, siRNAs directed to promoter genes can induce H3K9 and H3K27 methylation (Kim 
et al., 2006). It was found that besides chromatin modifying complexes, mammalian cells need 
Ago1 or Ago1&2 for siRNA-mediated transcriptional silencing (Janowski et al., 2006; Kim et al., 
2006). Furthermore, two different studies describe a role for promoter-directed human miRNAs 
in facilitating transcriptional gene silencing (Gonzalez et al., 2008; Kim et al., 2008). Promoter-
targeting RNAs have also been involved in activation of transcription (Janowski et al., 2007; 
Schwartz et al., 2008). These results suggest that small RNA-mediated DNA and histone 
modifications are also occurring in mammals and the discovery of endo-siRNA increases the 
chance that there will be more small RNAs involved in chromatin modification.  
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1.6 MiRNAs and target mRNAs 
The annotation of new miRNAs is based on several rules: expression of the new miRNA gene 
should be verified by experimental evidence and one of the following criteria should be met: (1) 
the mature miRNA should be included in one arm of a predicted fold-back precursor structure 
with extensive base-pairing in the miRNA region not containing any large internal loops or 
bulges, (2) the fold-back structure should be phylogenetically conserved and (3) the precursor 
should be shown to accumulate in organisms with impaired Dicer function (Ambros et al., 2003a; 
Mendes et al., 2009). These annotation criteria have inspired most current computational 
methods, however they differ in approaches to phylogenetic conservation and features to identify 
good stem-loop candidates (Berezikov et al., 2005; Grad et al., 2003; Lai et al., 2003; Lim et al., 
2003). More recent methods include “machine learning”, meaning they try to generalize from a 
positive set of known miRNA and a negative set of stem-loops (Mendes et al., 2009).  
An up to date collection of published miRNAs sequences is provided by miRBase 
(http://microrna.sanger.ac.uk/). The growing number of miRNAs identified in the most recent 
years is mainly due to the discovery of deep-sequencing technologies, which has opened doors 
to detecting and profiling known and novel, low abundant miRNAs. However, the identification of 
the large pool of sequenced transcripts from a deep sequencing run remains a major challenge. 
Mapping of the small transcripts is not trivial and miRNAs need to be separated from the pool of 
other sequenced small RNAs or degradation products. A number of bioinformatical algorithms 
help to analyze the huge datasets, among them miRDeep. The idea of miRDeep is to detect 
miRNAs by analyzing how sequenced RNAs are compatible with how miRNA precursors are 
processed in the cell (Friedländer et al., 2008).  
The understanding of the function and the biological impact of miRNAs are defined by the target 
mRNAs and the effect on their expression. Most miRNA binding sites are found in the 3ʼ UTR, 
however recent experiments showed that there are also miRNA binding sites in the 5ʼ UTR or 
the coding region mRNAs (Duursma et al., 2008; Lal et al., 2008; Ørom et al., 2008; Rigoutsos, 
2009; Tay et al., 2008). Number and position of binding sites can play important roles. More 
miRNA binding sites are more effective and two sites close together lead to cooperative action, 
meaning they are even more potent than two single sites (Saetrom et al., 2007). Moreover, the 
position within the 3ʼ UTR can be critical too. RNAs with binding sites in a AU-rich neighborhood, 
or not too far away from the stop codon and away from the center of long 3ʼ UTRs are more 
easily regulated (Grimson et al., 2007; Nielsen et al., 2007). Furthermore, a different study 
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shows that target accessibility might play an important role for the extent of repression (Kertesz 
et al., 2007).  
In plants, it is common that miRNAs match with near-perfect complementary to their mRNA 
targets whereas animal miRNAs usually only show complementarity between the miRNA-mRNA 
duplex from nucleotides 2 to 8 of the miRNA, the so-called seed sequence. Bulges and 
mismatches are present in the central region and therefore endonucleolytic target cleavage is 
excluded. In the 3ʼ half of the miRNA some bulges are allowed but there should be some 
complementarity particularly in nt 13 to 16, especially if matching in the seed region is 
suboptimal (Brennecke et al., 2005; Lewis et al., 2005). However, many miRNA-target site 
interactions violate the seed rule (Ha et al., 1996; Ørom et al., 2008; Reinhart et al., 2000; Stern-
Ginossar et al., 2007). Moreover, some sites are recognized by miRNAs whereas other regions 
showing similar or higher complementarity are not. This might be due to the interplay of different 
target sites and due to various proteins binding to the target mRNA. For example, HUR/ELAV1, 
an AU-rich element (ARE) binding protein associates with the 3ʼ UTR of the CAT1 mRNA after 
stress, relieving it from miR-122-mediated repression. By this CAT1 is recruited from p-bodies to 
the cytoplasm where it can associate with polysomes and become translationally active. 
(Bhattacharyya et al., 2006). A similar phenomenon was first discovered in Zebrafish. By binding 
U-rich mRNA regions of miR-430 targets, the RNA-binding protein Dead end (Dnd1) can block 
miRNA accessibility and therefore inhibit silencing (Kedde et al., 2007). MiRNA activity at 
synapses appears to be regulated in a similar manner. By adding a specific neurotrophic factor 
to neurons, miR-134-mediated repression of its mRNA target can be relieved (Schratt et al., 
2006). In contrast to factors relieving miRNA function there are proteins enhancing the activity. In 
C. elegans, the Trim-NHL protein NHL-2 is required for optimal let-7 and lys-6 miRNA activity 
(Hammell et al., 2009). In mammals, Trim32 plays a role in the enhancement of let-7a- mediated 
differentiation of neural progenitor cells by interacting with Ago1 (Loedige and Filipowicz, 2009; 
Schwamborn et al., 2009). As a conclusion, proteins that are not part of the miRNA complex can 
tune miRNA silencing. This makes miRNA target identification more challenging and it should be 
noted that it is important not to analyze single miRNA binding sites but to look at the whole 
context of the 3ʼ UTR.  
Since animal miRNA-mRNA duplexes contain mismatches, gaps and G:U wobbles, they are 
difficult to predict. Most approaches involve conserved 3ʼ UTR sites with favorable 
thermodynamic hybridization energies and use the detection of seed matches as a major 
condition. The current prediction programs as for example Target Scan, PicTar and EMBL 
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require strict seed base pairing and therefore have a high degree of overlap. However, there are 
still differences due to the different algorithms. Another problem is that different prediction 
programs use different UTR databases, miRNA sequences and different ranking of the results. 
Other approaches to predict miRNA targets include rules of target site recognition from 
confirmed targets (Mendes et al., 2009). Many of these methods successfully predict real miRNA 
targets, but the number of false positives remains high and ways to experimentally verify target 
mRNAs get more and more important. 
Besides bioinformatical target identification, several biochemical identification approaches have 
been done. Two labs performed proteome analysis after miRNA overexpression or deletion 
(Baek et al., 2008; Selbach et al., 2008). Other labs co-immunoprecipitated targets with Ago 
proteins (Beitzinger et al., 2007; Easow et al., 2007; Hammell et al., 2008; Hendrickson et al., 
2008; Karginov et al., 2007; Landthaler et al., 2008; Zhang et al., 2007). Similarly, Ago proteins 
were purified in a method named Hits-CLIP, where Ago-RNA complexes are cross-linked before 
purification to allow mapping of Ago-miRNA and Ago-mRNA binding sites (Chi et al., 2009). A 
third approach uses biotinylated RNAs to isolate miRNA targets (Orom and Lund, 2007). 
However, the false-positive rate of these target analysis remains high and experimental target 
approaches have to be further optimized. 
1.7 PiRNAs 
PiRNAs are single stranded RNAs of about 24-33nt in length and are not conserved between 
species. In contrast to animal miRNAs, they carry a 2ʼO-methyl modification at their 3ʼ end which 
is added by a RNA methyltransferase. PiRNAs are restricted to the germ line and bind to the 
PIWI subclass of Argonaute proteins (Aravin et al., 2006); (Girard et al., 2006). The Piwi clade 
consist of Piwi, Aubergine (AUB) and AGO3 in flies, Mili (Piwil1), Miwi (Piwil2) and Miwi2 (Piwil4) 
in mice and Hili (Piwil2) Hiwi1 (Piwil1), Hiwi2 (Piwil4) and Hiwi3 (Piwil3) in humans. 
1.7.1 PiRNA function and transposon silencing 
Mutations in Drosophila Piwi proteins lead to defects in oogenesis and depletion of germline 
cells whereas Aub mutations disrupt gametogenesis (Cox et al., 1998; Cox et al., 2000; Harris 
and Macdonald, 2001; Klattenhoff et al., 2007). In mouse, all Piwi proteins are important for 
spermatogenesis (Deng and Lin, 2002); (Kuramochi-Miyagawa et al., 2004); (Carmell et al., 
2007). The discovery of their small RNA binding partners helped to further elucidate the function 
of these proteins. The first population of RNAs binding to Piwi proteins was performed in 
Drosophila, where small RNAs mapping to repetitive elements were identified, leading to the 
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term repeat-associated small interfering RNAs (rasiRNAs) (Aravin et al., 2003), (Brennecke et 
al., 2007); (Saito et al., 2007); (Gunawardane et al., 2007). Similar RNAs have also been 
identified in mammalian testes and zebrafish where they were called piRNAs (Aravin et al., 
2006); (Girard et al., 2006) (Houwing et al., 2007). Sharing some common features, rasiRNAs 
are often refered to as a subgroup of piRNAs. In mammals, piRNA expression changes during 
stages of sperm development. Therefore, mammalian piRNAs can be divided into pre-pachytene 
and pachytene piRNAs according to the stage of meiosis at which they are expressed in 
developing spermatocytes. Pre-pachytene piRNAs predominantly correspond to repetitive and 
transposon rich sequences and interact with MILI and MIWI2 whereas pachytene piRNAs 
associate with MILI and MIWI (Aravin et al., 2006; Aravin et al., 2007; Aravin et al., 2008; Girard 
et al., 2006; Kuramochi-Miyagawa et al., 2008). Plants lack Piwi proteins but have a different 
RNAi-based strategy for transposon control. In Arabidopsis, Ago4 is loaded with transposon-
derived small RNAs and involved in silencing of transposable elements (Slotkin and 
Martienssen, 2007).  
Besides piRNAs there are also transposon-derived endo-siRNAs. Transcripts from some mobile 
elements are derepressed in ago2 mutant heads and ovaries, dicer-2 mutant heads and dicer-2 
and ago2 knockdown S2 cells (Chung et al., 2008; Czech et al., 2008; Ghildiyal et al., 2008; 
Kawamura et al., 2008; Rehwinkel et al., 2006). These studies show that the endo-siRNA 
pathway contributes to transposon repression. It is possible that in the germline the piRNA 
pathway and the endo-siRNA pathway cooperate with each other. In the male germline, piRNA 
pathway mutations have a severe effect on fertility whereas it appears to be dispensable in the 
female germline of mammals, which contain a rich endo-siRNA population (Tam et al., 2008; 
Watanabe et al., 2008). With the exception of the esi-2-endo-siRNA, the role of endo-siRNA 
processed from structured loci and convergent transcripts needs to be further investigated 
(Czech et al., 2008; Okamura et al., 2008b).  
1.7.2 PiRNA biogenesis 
Although there are thousands of piRNAs identified they derive from discrete genomic clusters 
(Aravin et al., 2006; Girard et al., 2006). PiRNA biogenesis was best studied in Drosophila. Piwi 
and Aubergine bind piRNAs antisense to transposon RNAs whereas Ago3 typically binds the 
sense strands. AUB- and PIWI associated piRNAs show preference for a Uracil at their 5ʼ end, 
Ago3-associated piRNAs mostly have an adenine at nt 10. With the discovery that the first 10 nt 
of antisense piRNAs are often complementary to the sense piRNAs, the “ping pong” model has 
been proposed (Brennecke et al., 2007; Gunawardane et al., 2007). AUB or Piwi associated with 
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antisense piRNAs cleave sense retrotransposon transcripts thereby creating the 5ʼ end of sense 
piRNAs that then associate with Ago3. Ago3 then subsequently cleaves antisense 
retrotransposon transcripts generating the 5ʼ end of antisense piRNA that subsequently bind to 
Piwi. It is not known how the 3ʼ end of the piRNAs is generated. By this continuous cycle, 
piRNAs are amplified and retrotransposon silencing can be maintained. How piRNA biogenesis 
is initiated it not really understood. At least AUB and PIWI are maternally inherited to embryos. It 
is possible that piRNAs associated to those proteins act as primary piRNAs and initiate the ping-
pong cycle (Brennecke et al., 2007; Nishida et al., 2007).  
The ping-pong model found in Drosophila might also be applicable for mouse piRNAs. MILI 
cleaves the precursors thereby generating the 5ʼ end of the piRNA subsequently accepted by 
MIWI2. MIWI2 then cleaves the opposite strand precursor thereby generating the 5ʼ end of the 
piRNA subsequently binding to MILI. As in Drosophila it is not known how the 3ʼ end of the 
piRNA is generated. The ping-pong model is not applicable to pachytene piRNAs associated to 
MILI and MIWI and moreover it is unclear how primary piRNAs are processed (Aravin et al., 
2008).  
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1.8 Aim of the thesis 
Members of the Argonaute protein family are the major cellular protein interactors of small RNA- 
mediated gene silencing. However, many protein as well as RNA interactors of individual human 
Ago protein complexes are unknown so far. Therefore, the aim of this work was to biochemically 
characterize Ago1- and Ago2-containing protein complexes in human cells and analyze their 
protein content and small RNA components. 
Previous biochemical purifications of Ago proteins have already identified several protein 
interacting partners, many of them being directly involved in the miRNA biogenesis pathway. 
However, it is not known how many additional proteins are required for gene silencing. New 
interaction partners of Ago proteins might help to get more insight into the mechanistic detail of 
gene silencing, which is so far still not fully understood. In addition, it would be interesting to find 
out if proteins bound to target mRNAs can interact with Ago and thereby effect silencing. 
Furthermore, there might be factors promoting or inhibiting Ago binding to their targets. One aim 
of the thesis was therefore to contribute to a more comprehensive analysis of different Ago 
complexes and their protein network. For this purpose, Ago1 and Ago2 complexes were purified 
and separated by gradient centrifugation. Protein components were identified by mass 
spectrometry and Ago interacting proteins were validated by different experimental approaches.  
The second aim of the thesis focused on small RNA binding partners of Ago proteins, known to 
bind to a variety of small RNAs with different biogenesis and function, such as miRNAs, siRNAs 
and piRNAs. In humans, four different Ago proteins seem to associate with the same miRNA 
species regardless of their sequence, as shown in previous results (Meister et al., 2004). 
However the full spectrum of Ago1- and Ago2-associated small RNAs, their individual biogenesis 
pathway and potential targets in human somatic cells is still not known. The aim of the thesis 
was to analyze the small RNA components bound to Ago proteins in order to identify new small 
RNA species by small RNA cloning and deep sequencing. The processing and function of the 
new identified small RNAs were analyzed and characterized by using different biochemical and 
molecular biological approaches.  
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2 Results 
2.1 Analysis of Argonaute containing mRNA protein complexes in 
human cells 
Members of the Argonaute protein family are key components of RNA silencing effector 
complexes. They are guided to their targets by small RNAs and can induce RNA cleavage, 
translational repression and/or deadenylation, depending on the complementarity of the small 
RNA and its respective target. The identification of different Ago protein complexes will lead to a 
better understanding of miRNAs and their function and help to elucidate the mechanisms of 
gene silencing.  
2.1.1 Ago1 and Ago2 are incorporated into three distinct protein complexes 
For a detailed characterization of Argonaute proteins Ago1 and Ago2 containing complexes were 
biochemically purified and analyzed. Lysate from HEK 293 cells was separated by 15%-55% 
sucrose density gradient centrifugation. 23 fractions were collected and analyzed by western 
blotting using antibodies against Ago1 and Ago2 (Höck et al., 2007) (Fig. 2.1).  
 
 
 
Figure 2.1. Ago1 and Ago2 complexes reside in three different complexes 
 
 
Lysates from wild-type HEK 293 cells were separated by sucrose density centrifugation under conditions 
that allow the separation of mRNPs. Endogenous Ago1 and Ago2 of individual fractions were analyzed 
using anti-Ago1 (monoclonal) and anti-Ago2 (polyclonal) (Höck et al., 2007). 
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Both Ago1 and Ago2 were sedimenting in three different complexes referred to as complex I-III 
(Fig. 2.1). Complex I contains the largest Ago fraction (40-60%) and has a molecular weight of 
about 250-350 kDa. Complex II has a molecular weight of about 600-700 kDa or 19S and 
complex III sediments at a molecular weight of more than 900 kDa or 25-30S. Complex II and III 
are RNAse A sensitive (Höck et al., 2007). Moreover, a luciferase reporter construct carrying the 
3ʼUTR of KRAS mRNA, known to be regulated by let-7a, sediments with complex III when 
transfected to 293 cells and analyzed by gradient centrifugation as described above (Höck et al., 
2007; Johnson et al., 2005). This suggests that complex III contains mRNPs with miRNA targets. 
Since Ago proteins are key components in RNA silencing and act as guides for small RNAs, the 
miRNA association of the three complexes was analyzed by semi-quantitative PCR. Two 
different miRNAs, namely miR-16 and let-7a are found to associate with all three Ago complexes 
as described by Höck et al. (Höck et al., 2007). 
For further characterization, immunoprecipitates of the three complexes were required. As the 
Ago antibodies used for western blotting were not efficient enough for immunoprecipitation, the 
experiments were recapitulated with tagged Ago1 and Ago2 proteins. Lysate from HEK 293 cells 
transiently transfected with Flag-HA-Ago1 and Flag-HA-Ago2 expressing plasmids was 
separated by 15%-55% sucrose density gradient centrifugation. The fractions were collected and 
analyzed by western blotting using anti-HA antibodies (Fig. 2.2). Both Flag-HA-Ago1 and Flag-
HA-Ago2 showed the same sedimentation pattern as described for endogenous Ago1 and Ago2 
(Fig. 2.1). Therefore the tagged constructs were used for further analysis.  
 
 
 
Figure 2.2. Flag-HA tagged Ago1 and Ago2 complexes associate with native protein complexes 
 
 
HEK293cell extracts containing Flag-HA–Ago1 (upper panel) or Flag-HA–Ago2 (lower panel) were 
separated by gradient centrifugation. The presence of Flag-HA–Ago1 and Flag-HA–Ago2 was analyzed by 
western blotting using HA antibodies. 
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To identify cofactors of Ago1 and Ago2 residing in the three different complexes, lysates 
transfected with plasmids expressing Flag-HA-Ago1 and Flag-HA-Ago2 were loaded onto a 15-
55% sucrose gradient. Subsequent to fractionation by density centrifugation fractions 3-8, 10-13 
and 15-18 representing complex I, II and III respectively, were pooled and immunoprecipitated 
using anti-FLAG or control antibodies. The co-immunoprecipitated proteins were separated by 
SDS-PAGE and further analyzed by mass spectrometry. The proteins specifically purified with 
anti-FLAG antibody are summarized in (Table 2.1). A detailed analysis of the identified proteins 
is described in Höck et al. (Höck et al., 2007). 
2.1.2 RISC and Dicer activity associate with distinct Ago complexes 
A prominent interaction partner of Ago proteins is Dicer. A region in the PIWI domain of Ago 
proteins binds directly to the RNAse III domain of Dicer (Tahbaz et al., 2004). The two proteins 
form a stable complex that can generate small RNAs from dsRNA precursor (Gregory et al., 
2005). In the mass spectrometry results (Table 2.1) Dicer was found to reside in two different 
complexes, complexes I and III. To further verify this, lysates expressing Flag-HA-Ago1 and 
Flag-HA-Ago2 were analyzed by density gradient centrifugation as described above. Individual 
fractions were immunoprecipitated using an anti-HA antibody and incubated with in-vitro 
transcribed and P32 labeled pre-miR 27 transcripts. Cleavage products were analyzed by 
denaturing RNA-PAGE (Fig. 2.3A). Consistent with the mass spectrometry results, a cleavage 
product of about 22nt in length is observed in complexes I and III whereas no cleavage product 
can be detected in complex II. The same results are obtained with lysates transfected with Flag-
HA-Dicer expressing plasmids.  
In humans, Ago 2 has been shown to cleave the target mRNA opposite of nt 10 and 11 of the 
miRNA (Liu et al., 2004; Meister et al., 2004; Rivas et al., 2005). To investigate in which of the 
three complexes resides RISC activity, lysate from HEK 293 cells transiently transfected with 
Flag-HA-Ago2 expressing plasmids was separated by sucrose density gradient centrifugation as 
described above. The individual fractions were immunoprecipitated using anti-HA antibody, 
incubated with a 32P-cap labeled artificial target mRNA bearing a region fully complementary to 
endogenous miR-19b. Cleavage products were observed by denaturing RNA-PAGE (Fig. 2.3B). 
Cleavage activity is immunoprecipitated with individual fractions of complex I whereas no 
cleavage signal is observed in any other higher molecular weight fractions. This indicates that 
Ago2 complex I represents human RISC. 
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Figure 2.3. Dicer and RISC activity reside in distinct complexes 
 
 
(A) Lysates from Flag-HA–Ago2-transfected HEK293 cells were separated and immunoprecipitated as 
described in Figure 2.1. The immunoprecipitates or recombinant Dicer were incubated with an internally 
labeled pre-miR-27a substrate. A21-nucleotide marker is shown to the left. (A) Flag-HA–AGO1-containing 
HEK293 lysate was separated and immunoprecipitated as described in Figure 2. Immunoprecipitates were 
incubated with a 32P-cap-labelled RNA, which contained a perfect complementary sequence to the 
endogenous miR-19b. Lanes indicated with T1 show RNaseT1 digestions of the RNA substrates. The 
RNA sequence complementary to miR-19b is indicated by a black bar on the right. 
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2.1.3 Ago complex I consists of distinct subcomplexes 
There is a huge number of proteins found in Ago complex I, which would form a much bigger 
complex than the actual molecular weight of about 250-350 kDa. For further separation of 
potential smaller complexes, lysates transfected with plasmids expressing Flag-HA-Ago1 and 
Flag-HA-Ago2 were loaded onto a 5-25% sucrose gradient. After density centrifugation individual 
fractions were analyzed by western blotting using anti-HA antibodies. Ago complex II and III 
migrate at the bottom of the gradient whereas complex I is present in almost all fractions (Fig. 
2.4). 
To be able to differentiate between different subcomplexes, fractions were analyzed for Dicer 
activity. Flag-HA-Ago2 was immunoprecipitated from individual fractions of a 5-25% gradient 
using anti-Flag antibodies. The precipitated complexes were incubated with in-vitro transcribed 
and 32P labeled pre-miR 27 transcript and cleavage products were analyzed by denaturing RNA-
PAGE (Fig. 2.5A). Dicer activity can be observed in fractions 9-13 with a peak in fraction 10. To 
get more insight into the different subcomplexes fractions were analyzed for Slicer activity. Flag-
HA- Ago2 was immunoprecipitated as described above and incubated with a P32-cap labeled 
substrate RNA complementary to the endogenous miR-19b. RISC activity can be observed in 
fractions 4-14 (Fig. 2.5B). Slicer and Dicer activity assays suggest that Ago2 complex I consists 
indeed of multiple subcomplexes here referred to as complex I a-c. 
 
 
 
Figure 2.4. Ago complex I consists of distinct subcomplexes 
 
 
HEK293 lysates containing FLAG-HA-Ago1 or FLAG-HA-Ago2 were separated by sucrose gradient 
centrifugation ranging from 5% to 25%. Individual fractions were analyzed by western blotting using anti-
HA-antibodies 
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Figure 2.5. Ago subcomplex I shows different Dicer and RISC activities 
 
 
(A) Flag-HA–Ago2 was immunoprecipitated from the gradient fractions using anti-FLAG antibodies and 
incubated with an internally labeled pre-miR-27a substrate. Recombinant Dicer was used incubated with 
the same substrate as a positive control. A 21-nucleotide marker is shown to the left. (B) 
Immunoprecipitates were incubated with a 32P-cap-labelled RNA, which contained a perfect 
complementary sequence to the endogenous miR-19b. Lanes indicated with T1 show RNaseT1 digestions 
of the RNA substrates. The RNA sequence complementary to miR-19b is indicated by a black bar on the 
right. 
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Complex Ia might represent Ago on its own. Complex 1b associates with Dicer as well as RISC 
and could therefore be identical with a previously described trimeric complex consisting of Ago, 
Dicer and TRBP (Gregory et al., 2005). Complex Ic might interact with other proteins identified 
by mass spectrometry.  
In summary, it was shown that Ago1 and Ago2 complexes can be separated into three distinct 
complexes using density gradient centrifugation. All complexes can bind miRNAs. Previously 
validated miRNA targets sediment in complex III, suggesting that this complex forms large 
mRNPs with miRNA target mRNAs. Dicer activity associates with complex I, which is the 
smallest complex, and complex III, the largest complex. RISC activity is only observed in 
complex I. Furthermore, complex I consist of at least three different subcomplexes with minimal 
RISC as complex Ia and the trimeric complex Ago, Dicer and TRBP as complex Ib. Moreover, 
mass spectrometry results of the three main Ago complexes give more detailed information of 
the Ago protein interaction network. 
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Table 2.1 Proteins associated with human Ago1 and Ago2 
Name Domains/motif Ago1- 
complex  
Ago2- 
complex 
Acc. No. 
Proteins involved in gene silencing 
Dicer DEAD box, RNase III, PAZ, dsRBD, 
DUF 
I, III I, III* gi|21665773/ 
gi|5019620 
TNRC6B RRM - I gi|14133235 
MOV10 DExH box III III gi|14424568 
TRBP dsRBD I* I* gi|107904 
Gemin3 DEAD box  II* gi|14209614 
Gemin4 Leucin Zipper II*, III II, III gi|7657122 
DEAD/DEAH box containing proteins 
RNA helicase A 
(RHA)/ 
DHX9 
DEAH box, helicase domain, dsRBD, 
DUF1605 
II, III  II, III gi|1806048/ 
gi|1082769 
DHX30 DEAH box, helicase domain, dsRBD, 
DUF1605 
II, III II, III gi|20336294  
RENT1/Upf1 DEAD box, exoV III - gi|1575536 
DHX36 DEAH box, helicase domain, 
DUF1605 
II*, III* II* gi|7959237/ 
gi|23243423 
DDX21/RNA 
helicase 
GuA 
DEAD box, helicase domain, GUCT II, III II gi|2135315 
DDX50/RNA 
helicase 
GuB 
DEAD box, helicase domain, GUCT, 
RESIII 
III - gi|55664207 
DDX46 DEAH box, helicase domain, 
DUF1605  
II* II* gi|2696613 
DDX48 DEAD box, helicase domain II*, III - gi|496902 
DDX18 DEAD box, helicase domain III - gi|1498229 
DDX5/p68 DEAD box, helicase domain - II*  
DDX39/BAT1 DEAD box, helicase domain III* II* gi|1905998 
DDX47 DAED box, helicase domain, 
Apolipoprotein L  
III - gi|20149629  
hnRNPs 
hnRNP-U SAP, SPRY, SCOP II, III II, III gi|32358 
hnRNP-U-like SAP, SPRY, SCOP I* -  gi|3319956 
hnRNP-H2/H’ RRM, RNPHF zinc finger II* - gi|6065880 
hnRNP-F RRM, RNPHF zinc finger II* I* gi|16876910 
hnRNP-C RRM II, III II, III gi|13937888/ 
gi|14250048 
hnRNP-E2 KH1, KH2 III* -  
NSAP1 Phox-like, PX-associated motif, RRM II, III - gi|5031512  
hnRNP-L Enoyl-CoA hydratase/isomerase, 
RRM 
III* - gi|11527777  
mRNA binding proteins 
Poly-A binding 
proteins 
RRM II, III II, III gi|46367787/ 
gi|693937 
Nuclear cap 
binding 
protein 
80kDa 
MIF4G III - gi|3153873 
YB-1 Cold shock domain II II, III gi|181486/ 
gi|55451 
FMRp Agenet, KH1 III* - gi|182673 
FXR1 Agenet, KH1 - III gi|1730139 
FXR2 Agenet, KH1 III - gi|4758410 
ZBP-1 RRM, KH1  II, III III gi|7141072/ 
gi|56237027 
ZBP-3 RRM, KH1 III - gi|30795212 
HuR RRM III* - gi|1022961 
RBM4 RRM, Zn-finger - III* gi|4506445 
Proteins involved in RNA metabolism 
NF90/ILF3/ 
NFAR-1 
dsRBD, DZF II, III II gi|1082856/ 
gi|5006602 
NF45/ILF2 DZF II, III II, III gi|532313 
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*identified by a single peptide 
SART3 Lsm interaction motif, RRM I, II, III - gi|7661952 
RBM10 D111/G-patch, RRM, zn finger, Ran 
binding 
- I*, II* gi|12644371 
Fibrillarin Fibrillarin motif - II*, III* gi|182592 
NOP56 Pre-mRNA processing RNP, 
NOP5NT, NOSIC 
III - gi|2230878  
Nucleolin RRM III - gi|128841 
eIF2bδ Initiation factor 2B I* - gi|6563202 
eIF4b RRM - I* gi|288100 
FLJ20758 Pentatricopeptide repeat II II gi|38683855 
Other proteins 
Myb binding 
protein 1a 
DNA polymerase V III III* gi|7657351 
Matrin 3 RRM, Zn finger III* III* gi|6563246 
Motor protein - II, III  gi|516764 
ZNF326 AKAP95 II, III - gi|31807861/ 
gi|47125447 
Ku70 Ku70/80 motif, DNA binding SAP - II* gi|57165052 
DDB1 CPSF A subunit I I* gi|418316 
RuvB-like II AAA ATPase, Tip49b I I, II gi|5730023/ 
gi|12653319 
Coatomer protein WD-40, COPB2 III II gi|1002369 
Results  34 
2.2 Argonaute proteins and their small RNA binding partners 
Besides the biochemical isolation and identification of human Ago1 and human Ago2 protein 
complexes the aim of this thesis was to analyze the small RNA components of Ago proteins. 
Members of the Ago protein family are key components of RISC complexes. They are guided to 
their targets by small RNAs. Depending on the complementarity of the small RNA and its target 
they can lead to target RNA cleavage, translational repression and/or deadenylation (Peters and 
Meister, 2007). For a detailed characterization of Argonaute proteins, monoclonal antibodies 
specific for Ago1 and 2 were generated. For their characterization, plasmids expressing FLAG-
HA-tagged Ago1 and Flag-HA-Ago2 were transfected into HEK293 cells. After 
immunoprecipitation with anti-Ago1 and anti-Ago2 antibodies, proteins were analyzed by 
western blotting using anti-HA antibodies (Fig. 2.6). All antibodies immunoprecipitated only one 
specific Ago protein. Therefore, they can be used as powerful tools to purify endogenous Ago 
complexes and analyze protein-components, associated mRNAs and associated small RNAs. 
For more detailed antibody characterization see also Beitzinger et al. and Rüdel et al. (Beitzinger 
et al., 2007; Rüdel et al., 2008). 
 
 
 
Figure 2.6 Characterization of monoclonal anti-Ago1 and anti-Ago2 antibodies  
FLAG-HA-tagged Ago1-4 were subjected 
to immunoprecipitations using anti-
Ago1(4B8) (lanes 1–4), anti-Ago2(11A9) 
(lanes 5–8), and anti-FLAG (lanes 9–12) 
antibodies. Immunoprecipitated FLAG- 
HA-Ago proteins were analyzed by 
western blotting using anti-HA antibodies.  
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2.2.1  Small RNAs associated with human Ago1 and Ago2 
Since there are several Ago paralogs in an organism it is intriguing to find whether every small 
miRNA species can be incorporated into all of them or whether certain miRNAs are selectively 
incorporated into a specific Ago protein. Ago sorting is best studied in Drosophila, where the 
structure of the precursor is the major determinant of sorting small RNAs into Ago proteins. 
Duplexes with central mismatches are preferentially sorted into Ago1 whereas perfectly 
complementary duplexes are sorted into Ago2 (Förstemann et al., 2007; Tomari et al., 2007). 
 
 
 
Figure 2.7. Cloning and library generation of small RNAs for 454 sequencing 
 
 
(A) Endogenous Ago1 and Ago2 complexes were immunoprecipitated using the specific monoclonal 
antibodies described in Figure 2.6. An anti-FLAG or an anti-GST antibody served as controls. Without any 
size fractionation, extracted Ago-associated RNAs were poly(A)-tailed and an adaptor was ligated to the 5ʼ 
phosphate of the miRNAs. First-strand cDNA synthesis was performed using an oligo(dT)- linker primer 
and reverse The resulting cDNAs were PCR amplified in 22 cycles. (B). The 120–135 bp amplification 
products were loaded onto an agarose gel and visualized by ethidium bromide staining. Massively parallel 
sequencing was performed by 454 Life Sciences (Branford, USA) and MWG Biotech (Germany) using the 
Genome Sequencer 20 system.  
Results  36 
Similarly, in C. elegans small RNAs from mismatched or perfect precursors are incorporated into 
the Ago proteins ALG-1 or RDE-1 respectively (Steiner et al., 2007). In humans, four different 
Ago proteins seem to associate with the same miRNA species regardless of their sequence 
(Azuma-Mukai et al., 2008; Meister et al., 2004). However the spectrum of Ago-associated small 
RNAs in human somatic cells is presently not known. Therefore, monoclonal antibodies specific 
to human Ago1 (4B8) and Ago2 (11A9) were used for Ago isolation from total HEK 293 cell 
lysates. Co-immunoprecipitated RNAs were extracted and cloned without size fractionation as 
described in Figure 2.7. Moreover, the new deep sequencing technologies bring major 
advantages, as there is no need for cloning into bacterial vectors and for amplification and 
purification of individual templates. Briefly, the DNA library is mixed with capture beads (carrying 
complementary sequences to the library adapters), PCR reagents and oil, creating an emulsion. 
The oil droplets function as tiny microreactors where the DNA is amplified, still immobilized on 
the beads. After the PCR reaction is complete, the DNA containing beads are isolated and 
placed into a PicoTiterPlate for sequencing. Each Plate contains 1.6 million wells and only a 
single capture bead fits into each well. After loading of tiny enzyme beads, the plate is placed 
into the 454 Sequencing System instrument. Bases are flown sequentially and always in the 
same order across the plate. A nucleotide complementary to the template is incorporated and 
releases pyrophosphate. Addition of adenosine 5ʼ phosphosulfate (APS) and luciferin allows 
ATP sulfurylase to convert pyrophosphate and APS to ATP. Luciferin is oxidated by luciferase in 
the presence of ATP and emits light, which is recorded by a CCD camera. Finally, a software 
generates a flowgram for each well, which can be further analyzed (454 technology). 20448 
sequenced reads were found to be associated with the Ago1 and 42604 reads with the Ago2 
library. All reads with known annotation are depicted in a pie chart (Fig. 2.8). More than 80% 
could be annotated to miRNAs; however there were also some reads mapping to snoRNAs, 
mRNAs, other non-coding RNAs and transposons (Fig. 2.8A-C). Using a Dicer substrate 
identification algorithm (miRDeep), the presence of 158 known miRNAs in the combined Ago1 
and Ago2 libraries was confirmed (Friedländer et al., 2008). All miRNAs that are present in the 
libraries bind to Ago1 as well as Ago2 (see Appendix for individual numbers of miRNAs). 
However, plotting individual reads of Ago1 bound miRNAs against Ago2 bound miRNAs shows 
that some show a higher relative abundance in one or the other library, suggesting a preferential 
binding to either Ago1 or Ago2 (Fig. 2.9). This is consistent with the published data on Ago2 and 
Ago3 miRNA association (Azuma-Mukai et al., 2008). Using miRDeep, 8 new miRNA candidates 
could be identified, as shown in Fig 2.10. Candidate 7 is particularly interesting as it is localized 
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in an intron, directly flanked by exons. During its further analysis, this sequence was confirmed 
to be a miRNA that is Drosha independent but is directly liberated by splicing (Berezikov et al., 
2007). Moreover, all new miRNA candidates identified in this study were published by other labs 
during manuscript preparation of Ender et al. (Ender et al., 2008). 
 
 
 
 
 
 
 
Figure 2.8. Small RNAs associated with Ago1 and Ago2 
 
 
(A) Summary of the sequencing data obtained from deep sequencing of human Ago1 and Ago2 
associated small RNAs. (B and C) Schematic representation of individual small RNA classes that are 
associated with human Ago1 or Ago2 complexes. Only reads with known annotation are represented.  
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However, although candidate 4 (Fig. 2.10) was annotated as a miRNA it was found during this 
study that it maps to a sequence annotated as a snoRNA. More intensive analysis revealed that 
there are in all Ago-associated RNA libraries small RNAs with a length of about 20-22 nt 
mapping to snoRNAs. Interestingly, the sequenced reads derive only from one half of the 
snoRNA, either the hairpin formed by the 3ʼ half or the 5ʼ half. Both arms of the individual stems 
are present in the libraries and the sequence with the lower abundance is indicated as “star” 
sequences.  
2.2.2 SnoRNAs: structure, assembly and function 
SnoRNAs are small nucleolar RNAs of 60-300 nt in length existing as snoRNA:protein 
complexes (snoRNPs). They are well conserved and present in archaea as well as in 
eukaryotes, indicating that they arose over 2-3 billion years ago. SnoRNAs can be divided into 
two distinct classes: the box C/D and the box H/ACA snoRNAs (Fig 11). Box C/D RNAs are 
characterized by two sequence motifs, box C (UGAUGA) and box D (CUGA) which direct 
 
 
 
Figure 2.9. Analysis of preferential Ago binding of miRNAs 
 
 
 
 
 
 
 
 
Plotting the 30 most abundant miRNAs 
immunoprecipitated with Ago1 and Ago2 
complexes. All reads annotated as 
miRNA for Ago1 and for Ago2 libraries 
respectively, equals 100%. Individual 
numbers of all miRNA reads are shown in 
the appendix.  
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Figure 2.10. New miRNA candidates identified with miRDeep 
 
 
(1) This candidate precursor is located in an intron in the sense orientation. It has a total frequency of 28 
reads mappings. It is now annotated as hsa-miR-1180 (Subramanian et al., 2008). 
(2) This candidate precursor is well conserved and is predicted to have a conserved secondary structure. 
The mature sequence is very similar to the human hsa-miR-190 sequence. It has a read frequency of two 
reads. It is been annotated as hsa-miR-190b (Landgraf et al., 2007).  
(3) The precursor of candidate 3 is located in an intron in the sense orientation. It has a total frequency of 
43 reads mapping. It has been annotated as hsa-miR-942 (Lui et al., 2007). 
(4) This candidate precursor is well conserved and is located in an intron in the sense orientation. It has a 
frequency of five reads and has now been annotated as hsa-miR-942 (Lui et al., 2007). Interestingly, it 
maps to a sequence annotated as snoACA36B (see also figure 2.22). 
(5) Candidate 5 is well conserved and is located in an intron in the sense orientation. It has a read 
frequency of four reads. It was predicted by Berezikov and has been annotated as hsa-miR-1301 
(Berezikov et al., 2006; Morin et al., 2008; Zhu et al., 2009).  
(6) This candidate precursor is well conserved and is located in an intron in the sense orientation. It is 
predicted to have a conserved secondary structure. The candidate mature sequence shares the nucleus 
sequence with the miR-96 family, but is not conserved beyond the nucleus. It has a read frequency of 14. 
It has been annotated as hsa-miR 1271 (Morin et al., 2008; Nygaard et al., 2009). 
(7) The mature and star sequences are conserved. It is located in an intron, flanked directly by exons. The 
read frequency is 18, and both mature and star sequences are represented. It has been annotated as hsa-
miR 877 and later identified as a mammalian mirtron (Berezikov et al., 2007; Landgraf et al., 2007). 
(8) This candidate precursor is well conserved and located in an intron in the sense orientation. It is 
predicted to have a conserved secondary structure. The mature sequence is very similar to members of 
the miR-374 family. It forms a cluster with the known hsa-miR-421. It has a read frequency of 42 reads 
and has been annotated as hsa-miR-374b (Landgraf et al., 2007). 
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Figure 2.11. Classes of snoRNAs and their protein partners 
 
 
Schematic representation of snoRNA structures. SnoRNAs can be divided into two major classes. On top 
the structure of the two classes are shown and below the protein partners are listed. (A) Box C/D snoRNA 
share the sequence motif PuUGAUGA (box C) and CUGA (box D) located near the 5`and or 3ʼ end 
respectively. In addition, most snoRNAs contain additional C- and D- like motifs termed boxes Cʼ and Dʼ. 
Sequences depicted in orange are usually complementary to conserved sequences of rRNAs. (B) Box 
H/ACA snoRNAs are characterized by the sequence motif ANANNA (box H) and ACA (box ACA). Box 
ACA is usually positioned three nt upstream from the 3ʼ end. H/ACA snoRNAs show a hairpin-hinge-
hairpin-tail secondary structure where each hairpin forms two duplexes with the rRNA (pseudouridinylation 
pocket, indicated in orange). It is possible that only one of the two antisense regions is functional, however 
the two modules do not function independently as it is observed for C/D box snoRNAs. Figure 2.11 is 
adapted from Dragon et al. (Dragon, 2006). 
 
 
 
binding of fibrillarin, Nop56p, Nop58p and 15.5K/NHPX/Snu13 snoRNP proteins. Box H/ACA 
carry the sequence motif box H (ANANNA – with N = any nucleotide) and ACA and are 
associated with Dyskerin/Nap57, NHP2, Gar1 and Nop10. Three of the four proteins are already 
associated with the H/ACA RNA during transcription. In addition, the nuclear assembly factor-1 
(NAF1), which already associates with Nap57 in the cytoplasm, binds to the transcript. This pre-
RNP is inactive until NAF1 is exchanged for GAR1, which only binds to functionally engaged 
snoRNPs (Fig. 2.12) (Darzacq et al., 2006; Matera et al., 2007).  
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Figure 2.12. Human H/ACA RNP assembly 
 
 
NAF1 associates with NAP57 and probably also already with NOP10 and NHP2 in the cytoplasm. The 
complex is recruited to the nucleus to the site of H/ACA RNA transcription where NAF1 is replaced by 
GAR1, leading the mature RNPs into the nucleolus 
 
 
 
SnoRNAs are involved in the processing or modification of ribosomal RNAs (rRNAs). The small 
and large subunit rRNAs are transcribed as part of a large precursor. After post-transcriptional 
modifications the precursor is subsequently cleaved and trimmed to release mature 18S, 5.8S 
and 25-28S rRNAs. The modified regions are key regions of rRNAs and are essential for 
ribosome function. Most snoRNAs are rather involved in modification than in processing of pre-
rRNAs. C/D RNAs direct 2ʼO-ribose methylation. H/ACA RNAs guide pseudouridinylation 
(conversion of uridine to pseudouridine). Forming direct base-pairing interactions with the 
substrate RNA, a feature that is also known for miRNAs, specifies the sites of modification. Both 
2ʼ-O-methylation and pseudouridinylation change the chemical nature of RNA and therefore its 
structure. Besides rRNA maturation, snoRNAs are also involved in snRNA modifications in 
eukaryotes, transfer RNAs in Archaea, spliced leader RNAs in trypanosomes and for telomere 
synthesis (Darzacq et al., 2002); (Dennis et al., 2001); (Uliel et al., 2004); (Collins, 2006). 
Moreover, there is still a high number of orphan snoRNAs that do not target established 
substrates indicating that snoRNAs also function on targets and in processes that remain to be 
identified. 
In contrast to yeast, most vertebrate snoRNAs are encoded in introns. Many derive from 
polycistronic transcripts containing several RNAs and only a few mammalian snoRNAs are 
known to be located in individual genes with their own promoters, typically transcribed by 
polymerase II. Genes containing intronic snoRNAs are often encoding proteins involved in 
ribosome assembly or nucleolar processes. However, the spliced RNA of some snoRNA host 
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genes do not have protein encoding potential and the functional product of these genes is 
contained in introns only (Dragon, 2006). Individual snoRNAs are liberated by splicing. After 
splicing, the intron lariat is degraded by exonucleases from both ends but trimming stops at the 
end of the snoRNA border, probably due to proteins bound to the RNA, together building the 
snoRNP. Boxes C/D, H and ACA may serve as binding sites for the snoRNP proteins. However, 
a few snoRNAs are not liberated by splicing but rather excised from the intron by endonucleases 
and subsequently trimmed by exonucleases. As a result of trimming, mature snoRNAs carry a 5ʼ 
phosphate and a 3ʼ OH.  
2.2.3 ACA45 processing products are conserved across species 
In the Ago-associated RNA libraries there were reads of about 22nt in length originating from 
snoRNAs, the most abundant one matching to snoRNA ACA45 (Fig 2.13A). This particular 
snoRNA was therefore chosen for further and more detailed studies. The sequenced reads of 
ACA45 derive only from the 3ʼ half of the snoRNA. To look for sequence conservation, the reads 
were mapped to different Solexa libraries made from total RNA. The human data consisted of 
the data sets produced for this study using the 454 Life Sciences technology, as well as a data 
set produced by deep sequencing the small RNA fraction of HeLa cells using the Solexa/Illumina 
technology (submitted to Gene Expression Omnibus database, GEO accession number 
GSE10829) (Friedlander et al., 2008). The mouse data sets were produced by deep sequencing 
of small RNAs from mouse brain and kidney tissues (unpublished data) and rat data was 
produced by deep sequencing of column-purified small RNAs from testes extracts, all of them 
using the 454 technology (GEO accession number GSE5026) (Lau et al., 2006). The last data 
set was obtained by sequencing small RNAs from dog lymphocytes using Solexa technology 
(GEO accession number GSE10825) (Friedlander et al., 2008). Mapping the snoACA45 reads to 
these different Solexa libraries revealed that they are conserved in mammals, suggesting that 
they are indeed specific processing products (Fig. 2.13B). 
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Figure 2.13. Conserved reads mapping to snoRNA associate with Ago1 and Ago2 libraries  
 
 
(A) Sequence reads found in Ago1 and/or Ago2 libraries are highlighted in orange and blue. Numbers of 
individual sequences are shown in parentheses. (B) Specific ACA45-processing products are conserved 
across species. The ACA45 sequences for homo sapiens, rattus norvegicus, mus musculus, and canis 
familiaris are shown by sequence and structure. Independent deep sequencing data from each species 
have been obtained and mapped against the corresponding homolog. The bars indicate the positions of 
mapped reads. The blue bars represent putative ʻʻmatureʼʼ Dicer products, while the red bars represent 
putative ʻʻstarʼʼ products. The numbers above the bars indicate the number of reads.  
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2.2.4  SnoRNA ACA45 is processed to small RNAs 
Homo sapiens ACA45 is predicted to guide pseudouridinylation of residue U37 for the 
spliceosomal U2 snRNA (Shibata et al., 1975). As a modification guide of RNA pol II-transcribed 
spliceosomal snRNA it presumably resides in Cajal bodies and is also known as scaRNA15. 
Cajal bodies are subcellular regions specialized for aspects of RNA biogenesis and function. 
ACA45 is 127nt in length and encoded within the large intron II (18497 bp) of the fibronectin type 
III and SPRY domain-containing protein 2. Although ACA45 was identified in a screen for 
functional snoRNAs, it is possible that it represents a miRNA gene that has been mis-annotated 
as a snoRNA (Kiss et al., 2004). In order to prove that ACA45 is indeed a functional snoRNA, 
GAR1 binding of ACA45 was analyzed (Fig. 2.14A). Endogenous GAR1 was 
immunoprecipitated from HEK293 total lysate using anti-GAR1 antibodies. Associated RNAs 
were extracted and further analyzed by northern blotting using a probe specific to ACA45. 
Indeed, full-length ACA45 was readily detectable in the anti-GAR1 but not in control 
immunoprecipitates. These data confirm that ACA45 represents a functional snoRNA.  
Fragments of about 22 nt in length mapping to the 3ʼ half of ACA45 were identified in the 
libraries of immunoprecipitated Ago1 and Ago2 complexes. The reads are conserved in different 
libraries sequenced from mammals, indicating that they are specific processing products. The 
processing of ACA45 to small RNAs could be validated by northern blotting (Fig. 2.14B). A probe 
complementary to the prominent sequence in the 5ʼ arm (Fig. 2.13A, blue) detected the full-
length ACA45 snoRNA as well as a band of approx. 22-23 nt in total RNA indicating that part of 
the cellular ACA45 pool is indeed processed to small RNAs. Since only a minor portion of 
ACA45 is processed to small RNAs it was furthermore investigated if ACA45 processing 
products are specifically enriched in Ago protein complexes. Endogenous Ago1 or Ago2 were 
immunoprecipitated from HEK293 total lysate using anti-Ago1 and anti-Ago2 antibodies and 
associated RNAs were analyzed by northern blotting against ACA45 processing products (Fig. 
2.14C). Consistently with the cloning data, the small RNA derived from ACA45 was indeed 
enriched in Ago1 as well as Ago2 immunoprecipitates, indicating that ACA45 processing 
products specifically associate with Ago proteins. This functional small RNA was therefore 
termed ACA45 small RNA (ACA45 sRNA).  
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Figure 2.14. SnoRNA ACA45 Is processed to small RNAs and associates with Ago1 and Ago2 
 
 
(A) ACA45 associates with the snoRNP component GAR-1. HEK293 lysates were immunoprecipitated 
using anti-GAR-1 (lane 3) or control antibodies (lane 4). Coimmunoprecipitated RNA was extracted and 
analyzed by northern blotting using a probe specific to ACA45 small RNA. Lane 2 shows total RNA 
extracted from 10% of the input lysate, and lane 1 shows a size marker. (B) Total RNA from HEK293 cells 
(30 µg) was blotted, and the membrane was incubated with a probe complementary to nt 65–85 (lane 2) 
of ACA45. A size marker is shown in lane 1. (C) Endogenous Ago1 (lane 2) or Ago2 (lane 4) were 
immunoprecipitated from HEK293 lysates, and the coimmunoprecipitated RNAs were extracted and 
analyzed by northern blotting. Lane 1 shows 10% of the extracts used for the immunoprecipitations, and 
lane 3 shows a control immunoprecipitation.  
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Figure 2.15. ACA45 sRNA can mediate RNA cleavage 
 
 
(A) A luciferase reporter construct containing a perfectly complementary binding site for the ACA45 sRNA 
or the empty vector was cotransfected with 2ʼ-O-methylated antisense inhibitors directed against the 
ACA45 sRNA. (B) The luciferase reporter described in (A), the empty vector, and a luciferase reporter 
containing a complementary binding site to miR-19b were transfected into HEK293 cells that have been 
pre- transfected with control siRNAs and siRNAs against Ago2. Firefly luciferase activity was normalized 
to renilla activity. Error bars are derived from four individual experiments.  
 
 
 
2.2.5 ACA45 small RNAs can function like miRNAs 
Since ACA45 processing products are similar to miRNA precursors, it was investigated if ACA45 
sRNAs are also functionally similar to miRNAs. To analyze this, a luciferase reporter construct 
containing a Renilla luciferase and a complementary binding site for the abundant 5ʼ arm of the 
snoRNA precursor downstream of a Firefly luciferase was generated (Fig. 2.15A). The luciferase 
plasmid was cotransfected together with 2ʻ O-methylated (2ʼ OMe) antisense inhibitors against 
ACA45 sRNA into HEK293 cells. Luciferase activity was strongly increased when endogenous 
ACA45-derived small RNAs were inhibited compared to cotransfection with a control 2ʻ OMe 
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oligo (Fig. 2.15B). Therefore, it can be concluded that the reporter construct cannot be cleaved 
upon inhibition of ACA45 sRNA. To analyze if the reporter cleavage is Ago2 dependent, the 
luciferase reporter was cotransfected with siRNAs against Ago2 and was compared to 
cotransfection with a control siRNAs. Indeed, luciferase activity was also increased, indicating 
that sACA45 is not cleavage competent upon Ago2 depletion (Fig. 2.15C). In summary, these 
data demonstrate that ACA45 small RNA can function like a miRNA.  
2.2.6 ACA45 processing is independent of the Drosha/DGCR8 complex  
Similar to miRNAs, ACA45 sRNA can cleave reporter constructs containing a perfectly 
complementary binding site in an Ago2 dependent manner. It was therefore intriguing to 
investigate whether also the processing of ACA45 is linked to the miRNA pathway. Primary 
miRNAs are usually cleaved by the microprocessor complex, containing the RNAse III enzyme 
Drosha and its binding partner DGCR8, into smaller precursors. The cleavage signature of the 
stem-loop-structured processing intermediate is different from the typical 2 nt 3ʼ overhangs 
generated by Drosha. However, Drosha and DGCR8 complex requirements for ACA45 
processing were tested by using in vitro as well as in vivo approaches. 
Plasmids expressing FLAG-HA-DGCR8 were transfected into HEK293 cells. After 
immunoprecipitation using anti-Flag antibodies purified proteins were incubated with either a 32P-
labeled primary miR-27a transcript or ACA45 and cleavage products were analyzed by 
denaturing RNA-PAGE (Fig. 2.16A). A specific cleavage product representing pre-miR-27a was 
observed in the anti-FLAG-HA-DGCR8 immunoprecipitates whereas no signal was observed 
when ACA45 was used as substrate.  
Drosha requirement was further investigated using the luciferase reporter construct described 
above (Fig. 2.16B). The reporter construct was cotransfected with siRNAs against Drosha and 
control siRNAs. Consistently with the in vitro results there was no elevated luciferase activity 
upon Drosha depletion, whereas luciferase activity of a miR-19b-responsive reporter was 
significantly increased. Taken together, the described results suggest that ACA45-processing is 
independent of the Drosha/DGCR8 complex.  
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Figure 2.16. ACA45 processing is independent of the microprocessor complex 
 
 
(A) FH-DGCR8 or untreated cells were immunoprecipitated using anti-FLAG antibodies. 
Immunoprecipitates were incubated with 32P-labeled pri-miRNA-27a (lanes 2 and 3) or ACA45 (lanes 4 
and 5). Lane 1 represents a size marker, and lanes 6 and 7 represent the protein input. (B) The luciferase 
reporter described in 2.15A, the empty vector, and a luciferase reporter containing a complementary 
binding site to miR-19b were transfected into HEK293 cells that have been pre-transfected with control 
siRNAs and siRNAs against Drosha. Firefly luciferase activity was normalized to renilla activity. Error bars 
are derived from four individual experiments. 
 
 
 
2.2.7 ACA45 processing requires Dicer 
After processing by the microprocessor complex and export to the cytoplasm pre-miRNAs are 
further processed by Dicer into small RNAs duplexes. The PAZ domain of Dicer preferentially 
recognizes 2 nt 3ʼ protruding ends. However, it was shown that with RNA tetraloops terminally 
blocked dsRNA can be cleaved internally (Zhang et al., 2004). Since ACA45 processing is 
independent of Drosha and DGCR8 it was investigated whether Dicer is required and might even 
be sufficient to cleave ACA45 into small RNAs.  
As it was shown in the first part of this work, Dicer activity can be coimmunoprecipitated with 
Ago proteins. Therefore, plasmids expressing Flag-HA-Ago1 (FH-Ago1), Flag-HA-Ago2 (FH-
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Ago2) or Flag-HA-Dicer (FH-Dicer) were transfected into HEK293 cells and immunoprecipitated 
using anti-HA antibodies. The complexes were incubated with a 32P labeled pre-miR-27a or full-
length ACA45 and analyzed on a denaturing RNA-PAGE (Fig. 2.17A). As expected, both Flag-
HA-Ago2 and Flag-HA-Dicer immunoprecipitates efficiently processed the pre-miR-27a. 
Furthermore, Flag-HA-Ago1, Flag-HA-Ago2 and Flag-HA-Dicer immunoprecipitates processed 
the 32P labeled full-length ACA45 as well, suggesting that Dicer is required for generation of 
ACA45 small RNAs.  
Notably, Dicer generates longer RNAs as well, which might represent processing intermediates 
(see asterisk in Figure 2.17A). To further investigate Dicerʼs function in ACA45 processing, it 
was analyzed if Dicer alone is sufficient for ACA45 processing in vitro. 32P-labeled ACA45 was 
incubated with increasing amounts of recombinant Dicer and cleavage products analyzed by 
RNA-PAGE (Fig. 2.17B). Indeed, recombinant Dicer produced small RNAs from the full-length 
ACA45 in a concentration dependent manner, suggesting that Dicer alone is sufficient for ACA45 
processing. Finally, the role of Dicer in ACA45 processing was analyzed in vivo. Total RNA from 
mouse embryonic stem (ES) cells carrying homozygous or heterozygous Dicer deletions 
(Murchison et al.,2005) was analyzed for the presence of ACA45 small RNAs by semi-
quantitative real time PCR (qRT-PCR) (Fig. 2.18A). Strikingly, no PCR product was detectable in 
the Dicer -/- cells, whereas a PCR product originating form the ACA45 small RNA was readily 
detectable in Dicer +/- cells (Fig. 2.18B). Notably, the full-length ACA45 was present in both 
Dicer -/- and Dicer +/- cells. Similar results were obtained when total RNA from Dicer -/- and 
Dicer +/- cells was analyzed by northern blotting using a probe complementary to the ACA45 
small RNA (Fig. 2.18C). In summary, these data indicate that Dicer processes ACA45 to small 
RNAs independently of the Drosha-containing microprocessor complex. 
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Figure 2.17. Dicer can process ACA45 into small RNAs 
 
 
(A) Flag-HA-Ago2 (lanes 4 and 10), FH-Ago1 (lanes 3 and 9), and FH-Dicer (lanes 5 and 11) were 
incubated with 32P-labeled pre-miR-27a (lanes 2–6) or ACA45 (lanes 8–12) and analyzed by RNA-PAGE. 
In lanes 6 and 12, lysate from untransfected HEK293 cells was used. Lanes 13–15 show anti-HA western 
blots of the protein input. Lanes 1 and 7 show size markers. (B) 32P-labeled pre-miR-27a (lanes 1–3) or 
ACA45 (lanes 5–7) were incubated with increasing amounts of recombinant Dicer. Cleavage products 
were analyzed by RNA-PAGE. Lane 4 shows a size marker. A putative processing intermediate is 
indicated by an asterisk.  
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Figure 2.18. Processing of ACA45 requires Dicer 
 
 
 
(A) RT PCR of small RNAs. After poly(A)-tailing of the RNAs, an oligo dT linker primer with a unique 
universal sequence (adapter) is annealed, followed by reverse transcription. The obtained cDNA can then 
be amplified using specific primers for the small RNA and the universal sequence. (B) Total RNA from 
Dicer􏰀+/- (lane 2) or Dicer􏰀-/-􏰀cells was analyzed by semi-qRT-PCR using primers specific for the ACA45 
sRNA (upper panel), miR-125b (middle panel), and 7SK RNA (lower panel). The origin of the PCR 
products indicated as A and B are highlighted in bold below the figure. (C) Total RNA from Dicer +/-􏰀 (lane 
1) or Dicer􏰀-/-􏰀 (lane 2) cells was analyzed by northern blotting using probes specific for the ACA45 small 
RNA described above. Lane 3 shows a size marker. 
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2.2.8 Validation of an endogenous ACA45-derived small RNA target 
It is thought that complementary Watson-Crick base pairing of the seed sequence (nucleotides 
2-8 counted from the 5' end) is a key feature of miRNA:mRNA target recognition. It is also known 
that highly conserved 7mers in 3' UTRs are often complementary to seed sequences of known 
miRNAs (Chen and Rajewsky, 2007). Remarkably, the seed of ACA45 22 nt long processing 
product is perfectly complementary to a significantly conserved 3' UTR motif (top 3% of all 
possible seed sites). Using the miRNA target prediction algorithm PicTar, several target mRNAs 
could be predicted for the ACA45-derived small RNA (Krek et al., 2005). For experimental 
validation, a number of 3ʼ UTRs selected from the predicted target mRNAs were fused to the 
luciferase reporter gene described above. Luciferase reporter constructs were cotransfected with 
2ʼ-OMe oligonucleotides antisense to the ACA45 small RNA. Many of the tested 3ʼ UTRs did not 
respond to the 2ʼ-OMe inhibitors suggesting that the small RNA does not target these mRNAs or 
that the small RNA – target mRNA interactions are not relevant in the tested cell line. Strikingly, 
the activity of the luciferase reporter fused to the CDC2L6 (CDK11) 3ʼ UTR is increased when 
the endogenous ACA45 small RNA is inhibited (Fig. 2.19A). The CDC2L6 gene product is a 
component of the mediator complex and therefore important for transcription (Conaway et al., 
2005a; Conaway et al., 2005b). For further validation of ACA45 sRNA effects on CDC2L6 
expression, all predicted ACA45 sRNA binding sites were mutated in the CDC2L6 3ʼ UTR (Fig. 
2.19C). Indeed, a luciferase reporter containing the mutated CDC2L6 3ʼ UTR was not 
upregulated when endogenous ACA45 sRNA was inhibited (Fig. 2.19B), indicating that ACA45 
sRNA seed sequence matches are important for CDC2L6 expression. In summary, these data 
demonstrate that ACA45 is processed to a small RNAs that can function like a miRNA on the 
endogenous target CDC2L6, identifying the ACA45 sRNA as potential transcriptional regulator in 
human cells. 
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Figure 2.19. ACA45-derived small RNAs regulated CDC2L6 expression  
 
 
 
(A) Luciferase reporter constructs containing the 3ʼ UTR of CDC2L6 or BAP-1 (no target) or the empty 
vector were cotransfected with increasing concentrations of 2ʼ -OMe inhibitors against the ACA45 sRNA. 
Firefly luciferase activity was normalized to Renilla activity. Error bars are derived from four individual 
experiments. (B) Luciferase reporter constructs containing the 3ʼ UTR of CDC2L6 or the CDC2L6 3ʼ UTR 
with mutated ACA45 sRNA-binding sites were cotransfected with 2ʼ -OMe inhibitors against the ACA45 
sRNA. Firefly luciferase activity was normalized to Renilla activity. Error bars are derived from four 
individual experiments. (C) Mutated ACA45 sRNA-Binding Sites of the 3′UTR reporter construct. The 
seed sequence of the ACA45 sRNA is shown in the upper panels and the binding sites on the CDC2L6 
3ʼUTR are displayed in the middle panels. Mutated binding sites are shown in the lower panels. Seed 
sequence binding sites and mutated nucleotides on the CDC2L6 3ʼUTR are highlighted in red and blue, 
respectively.  
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2.2.9 Small RNA processing signatures are not restricted to snoACA45 
The findings that ACA45 is processed into a small RNA repressing CDC2L6 led to the question 
whether this could be a more general fate for snoRNAs. The numbers of orphan RNAs that do 
not apparently target established substrates indicates that snoRNAs might indeed be involved in 
more cellular pathways. For a more comprehensive study anti-Ago1 and anti-Ago2 antibodies 
were used for Ago isolation from total HEK 293 cell lysates. After isolation, co-
immunoprecipitated RNAs were fractioned into RNA fragments of 19 – 24 nt in length and cloned 
as described in Fig. 2.20.  
 
 
 
Figure 2.20. Cloning and library generation of small RNAs for Solexa Sequencing 
 
 
(A) Endogenous Ago1 and Ago2 complexes were immunoprecipitated using the specific monoclonal 
antibodies described in Figure 2.6. RNA was size fractionated between 19 and 24 nt. The preadenylated 
3ʼ adapter was ligated to the 3ʼ hydroxyl group of the small RNA using a truncated T4 RNA ligase which is 
impaired in adenylate transfer from ATP to the 5ʼ phosphate of RNA. The 3ʼ adapter is blocked at the 3ʼ 
end with a C6 amino linker. 5ʼ adapter ligation is ligated with the classical T4 RNA ligase. After reverse 
transcription, the cDNA is amplified and analyzed on an Agarose gel after 15, 20 and 25 PCR cycles (B). 
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The generated libraries were subsequently sequenced by Illumina, which allows a higher 
quantity of sequence reads in parallel than 454 sequencing. Briefly, the DNA library is 
immobilized on a flow cell surface. Solid-phase amplification creates up to 1000 identical copies 
of each template. Because this process does not involve photolithography, mechanical spotting 
or positioning of beads into wells, very high densities of single-molecule clusters are achieved. 
Four modified fluorescently labeled nucleotides, primers and DNA polymerase are added. After 
laser excitation, the emitted fluorescence from each cluster is captured, the first base is identified 
and the next cycle can start. Finally, the sequencing results can be analyzed with the use of a 
specific software (Illumina Sequencing technology).  
About 5 million reads were found to be associated with the Ago1 and 4.5 million reads with the 
Ago2 library. All reads which could be annotated are depicted in the pie chart in (Fig. 2.21B/C) 
and a more detailed overview is given in Figure 2.21A. As for the 454 sequencing results, the 
majority of the reads could be annotated as miRNAs (Fig 2.21) but there were also reads 
mapping to snoRNAs, mRNAs, other non-coding RNAs and repetitive elements.  
To check if processing of snoRNAs into specific small RNAs is not restricted to ACA45, snoRNA 
reads from the Solexa library were studied in more detail. From 1909205 annotated reads 
associated to Ago1 and 2753916 associated to Ago libraries, 7218 or 4951 reads respectively 
could be mapped to snoRNAs. H/ACA Box RNAs and scaRNAs secondary structure consist of 
two hairpins. Figure 2.22 shows scaRNAs & H/ACA Box RNAs where at least 80% of all reads 
mapping to them come from the two strands of a stem-loop structure. Reads originating from 
stem-loop structures within the snoRNAs ACA45, ACA47, ACA36b, U92, HBI-100, ACA56, 
ACA3, ACA50 and U3 were identified. All the examples shown have reads in at least two data 
sets between Ago1-4 (Ago3 and 4 datasets are not discussed in this work) and most often in all 
four. Not all scaRNAs and H/ACA RNAs seem to have clearly the same processing signature. 
Most of them have a 3ʼ protruding end. Cleavage seems to occur at the hinge between the two 
hairpins of the scaRNA or H/ACA RNA. Interestingly, a similar signature, however without 3ʼ 
protruding end is present in the reads of the CD Box snoRNAs, U3. It has a different secondary 
structure, but does contain one hairpin. In summary, the data obtained from larger sequencing 
data sets suggest that processing of snoRNAs to functional small RNAs is not unique to ACA45 
and can be observed for other snoRNAs as well.  
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Figure 2.21. Small RNAs associated with Ago1 and Ago2 
 
 
(A) Summary of the sequencing data obtained from deep sequencing of human Ago1 and Ago2 
associated small RNAs. (B and C) Schematic representation of individual small RNA classes that are 
associated with human Ago1 or Ago2 complexes. Only reads with known annotation are represented. 
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Figure 2.22. Several human snoRNAs show miRNA-like processing signatures 
 
 
Schematic representation of the secondary structure of full-length snoRNAs. Ago-associated reads are 
highlighted in purple and yellow.  
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2.2.10 Small RNA reads mapping to tRNAs immunoprecipitate with Ago 
Besides reads mapping to snoRNAs a small portion of the Ago-associated small RNAs of 17-22 
nt in length were mapping to tRNAs (Fig. 2.8). The expression of two tRNAs referred to as tRNA 
LEU-3ʼ and tRNA HIS-3ʼ were validated by northern blotting (Figure 2.23B). They both derive 
from the 3ʼ end of a full length tRNA. Probes complementary tRNA LEU-3ʼ and tRNA HIS-3ʼ 
detected small RNAs of about 23-25 nt in length indicating that the identified small RNAs are 
indeed expressed in HEK 293 cells. Much stronger bands with sizes between 50 and 80 nt were 
observed for both RNAs, which may correspond to processing intermediates and full length 
tRNAs. It was furthermore investigated if the small tRNA fragments are specifically enriched in 
Ago protein complexes (Fig. 2.23C/D). Endogenous Ago2 was immunoprecipitated from 
HEK293 total lysate using anti-Ago2-11A9 antibody and associated RNAs were analyzed by 
northern blotting against tRNA processing products. Consistently with the cloning data, the small 
RNAs derived from tRNAs were indeed enriched in Ago2 immunoprecipitates, indicating that 
tRNA processing products specifically associate with Ago proteins.  
2.2.11 tRNA fragments mediate RNA cleavage in vitro 
Since tRNA fragments similar in length as miRNAs associate with Ago proteins it was 
investigated whether they can induce RNA cleavage. As described before, Ago2 has been 
shown to cleave the target mRNA opposite of nts 10 and 11 of the miRNA (Liu et al., 2004; 
Meister et al., 2004; Rivas et al., 2005). Therefore, Flag-HA-Ago1 and Flag-HA-Ago2 complexes 
were immunoprecipitated using anti-Flag antibodies and incubated with a 32P-cap labeled 
artificial target mRNA bearing a region fully complementary to endogenous tRNA LEU-3ʼ and 
tRNA HIS-3ʼ fragments. Cleavage products were observed by denaturing RNA-PAGE (Fig. 2.23). 
Indeed, both endogenous tRNA fragments directed Ago2-mediated cleavage (lanes 2 and 4). 
Ago1 that is catalytically inactive, does not co-purify with any cleavage activity although both 
tRNA fragments are found in the Ago1 library. These results suggest that small RNAs are 
generated from tRNAs that may function in an RNAi-like pathway. 
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Figure 2.23. tRNA fragments associate with Ago proteins 
 
 
(A) Sequence reads found in Ago1 and/or Ago2 454 libraries. Numbers of individual sequences are 
shown. (B) Total RNA from HEK293 cells (5 µg) was blotted, and the membrane was incubated with a 
probe complementary to tRNA HIS-3ʼ (lane 3) and tRNA LEU-3ʼ (lane 2). A size marker is shown in lane 1. 
(C; D) Endogenous Ago2 (lane 2) was immunoprecipitated from HEK293 lysates, and the 
coimmunoprecipitated RNAs were extracted and analyzed by northern blotting using the probe described 
above. Lane 3 shows a control immunoprecipitation. 
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Figure 2.24. tRNA fragments can mediate Ago2-dependent cleavage in vitro 
 
 
 
Immunoprecipitated Flag-HA-Ago1 and Flag-HA-Ago2 
were incubated with a 32P-cap-labeled RNA, which 
contained a perfect complementary sequence to the 
endogenous tRNA HIS-3ʼ and tRNA LEU-3ʼ. Lanes 
indicated with T1 show RNaseT1 digestions of the 
RNA substrates. The RNA sequence complementary 
to tRNA HIS-3ʼ and tRNA LEU-3ʼ is indicated by a 
black bar on the left. 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.12 tRNA processing is Dicer independent 
Finally, the role of Dicer in tRNA processing of the two candidates was analyzed in vivo. Total 
RNA from mouse embryonic stem cells carrying homozygous Dicer deletions was analyzed for 
the presence of tRNA LEU-3ʼ and tRNA HIS-3ʼ fragments by northern blotting. Probes 
complementary to both tRNA fragments detected small RNAs of about 23-25 nt in length in both 
wild type and Dicer depleted ES cells, indicating that the processing of tRNAs is Dicer 
independent. A northern blot using a probe complementary to miR-125 was used as control. As 
expected, miR-125 can be detected in wild type ES cells but not in Dicer depleted cells. 
Interestingly, northern blot analysis with immunoprecipitated RNA showed a much stronger 
signal for tRNA fragments in Dicer knockout cells compared to wild type cells. It is possible that 
due to the lack of miRNA, Ago has a higher capacity to bind Dicer independent tRNA fragments.  
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Figure 2.25. tRNA fragments are present in Dicer knockout cells 
 
 
(A, B) Total RNA and RNA from Ago2 immunoprecipitated complexes from Dicer knockout cells (lane A2 
and B3) or ES wild type cells (lane A1 or B2) were analyzed by northern blotting using probes specific for 
tRNA LEU-3ʼ and tRNA HIS-3ʼ small RNAs. Lane A5 and B1 show a size marker. (C) Northern blot as 
described above using probes against miR-125. (D) Protein levels of endogenous Ago2 detected by 
western blotting using anti-Ago2 (6F4).  
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3 Discussion 
3.1 Characterization of Ago-containing protein complexes 
Ago protein complexes are core components of RNA silencing effector complexes such as RISC 
or miRNPs and directly bind to small RNAs. To obtain further insight into the function of human 
Ago proteins, proteomic and biochemical approaches were performed to characterize so far 
unkown protein components of human Ago1- and Ago2- containing complexes. 
The results in this work indicate that both Ago1 and Ago2 reside in three distinct protein 
complexes ranging in size from 11S to more than 30S. The smallest complex, termed complex I, 
contains the largest Ago fraction (40-60%) and has a molecular weight of about 250-350 kDa. 
Complex II has a molecular weight of about 600-700 kDa or 19S and complex III sediments at a 
molecular weight of more than 900 kDa or 25-30S. Ago2 complex I shows RISC activity, 
whereas Ago complexes I and III are associated with Dicer. Interestingly, Ago complex II does 
not contain RISC and shows little detectable Dicer activity. Consistently with the observations by 
Dicer assays, Dicer was found in complexes I and III by mass spectrometry. However, low 
amounts of TRBP are identified only in Ago complex I. It could be possible that active Dicer 
complexes lacking TRBP exist. It was shown that TRBP knock down cells are still able to 
process pre-let-7a to mature miRNAs, however to a lesser extend compared to wild type cells. 
TRBP may facilitate pre-miRNA cleavage by Dicer but is primarily responsible for assembly and 
functioning of RISC (Haase et al., 2005). However, it is also very likely that TRBP was beyond 
detection level in the mass spectrometry results of this work.  
The Dicer containing complex I shows a huge number of proteins identified by mass 
spectrometry, which would form a much bigger complex than the actual molecular weight of 250-
350 kDa. Indeed, gradient centrifugation shows that complex I consists of three distinct 
subcomplexes referred to as complex I a-c with different Dicer and RISC activities. Complex Ia 
might represent Ago2 on its own. Complex 1b associates with Dicer as well as RISC and could 
therefore be identical with the described trimeric complex Ago, Dicer and TRBP (Gregory et al., 
2005). Complex Ic might interact with other proteins identified by mass spectrometry.  
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Besides Dicer, TRBP and a few already known interactors of Ago, many DEAD/H box-containing 
proteins have been identified. Among them are Gemin3 which has been found to sediment in a 
15S complex with Ago, and RHA (DEAH box polypeptide 9) which has been shown to be 
important for effective RNA silencing and probably RISC loading (Mourelatos et al., 2002; Robb 
and Rana, 2007). Moreover, DDX5, an ortholog of Drosophila p68, which has been shown to 
associate with Drosophila Ago2, and DDX18, a putative helicase that has been implicated in 
Drosha function (Gregory et al., 2004; Ishizuka et al., 2002) have been found. It is tempting to 
speculate that one of the DEAD/H proteins identified could be the helicase that promotes small 
RNA duplex unwinding. However, DExD/H proteins can also be implicated in remodeling or 
assembly of RNA complexes (Linder, 2006). 
Besides DEAH/D box helicases, isoforms of poly-A-binding proteins and many mRNA binding 
proteins involved in translation were present in the analysis, such as YB-1, ZBP1/3, HuR, RBM4, 
FMRp and its homologues FXR1 and FXR2. FXR has been identified in Drosophila RISC and 
FMRp has also been identified in humans (Caudy et al., 2003; Caudy et al., 2002). RBM4 was 
found to be important for cleavage of reporter constructs with a perfect complementary site to a 
miRNA or for repression of target RNAs (Höck et al., 2007). Surprisingly, RMB4 interacts with 
Ago in a RNA-dependent manner. It is possible that it helps recruiting Ago-miRNA complexes to 
their mRNA targets by further stabilizing the interaction of the miRNA with its target site.  
The identification of all these different proteins identified in complex II and III suggest that they 
both form large RNPs. Indeed, both complexes are RNAse sensitive. Moreover, the let-7 target 
KRAS co-migrates with Ago complex III in the Sucrose gradient, suggesting that complex III 
forms large mRNPs with Ago bound miRNAs targeting mRNAs. This does not allow for binding 
and cleaving of a substrate RNA and explains why complex III does not show RISC activity.  
In summary, the results presented here and the more comprehensive study in Höck et al. 
suggest that Ago complexes are recruited to miRNA target mRNAs carrying a variety of different 
RNA binding or regulatory proteins (Höck et al., 2007). miRNPs might then function in concert 
with this mRNA regulatory network unique to each individual mRNA and fine-tune translational 
regulation. It is therefore important to analyze miRNA function in the light of the whole protein 
network. Moreover, it suggests a way of identifying possible miRNA targets by 
immunopurification of Ago complexes and analysis of the precipitated mRNAs as it has recently 
been done by many laboratories (Beitzinger et al., 2007; Easow et al., 2007; Hammell et al., 
2008; Hendrickson et al., 2008; Karginov et al., 2007; Landthaler et al., 2008; Zhang et al., 
2007). 
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3.2 Small RNA binding partners of Argonaute proteins 
Besides the biochemical isolation and identification of human Ago1 and human Ago2 protein 
complexes a second aim of this thesis was to analyze the small RNA components of Ago protein 
complexes. It has been proposed before, that in humans, four different Ago proteins seem to 
associate with the same miRNA species regardless of their sequence (Azuma-Mukai et al., 
2008; Meister et al., 2004). However, a detailed analysis of Ago1- and Ago2-associated RNA 
species has not been done. Therefore, monoclonal antibodies specific to human Ago1 and Ago2 
were used for Ago isolation from total HEK 293 cell lysates. Co-immunoprecipitated RNAs were 
extracted, cloned and sequenced. Ago proteins are the cellular binding partners of small RNAs 
and it is not surprising that a high amount of miRNAs could be identified in the libraries. 
Interestingly, there were also some reads mapping to snoRNAs, mRNAs, other non-coding 
RNAs and transposons. Most published cloning approaches used total RNA for cloning of small 
RNAs and therefore unspecific degradation products of larger RNAs are present in the libraries 
and it is difficult to find classes of functional RNAs. However, in this work immunoprecipitated 
endogenous Ago complexes were analyzed it is very likely that small RNAs that associate with 
Ago proteins are functional RNA molecules rather than just degradation products.  
3.2.1 A human snoRNA acting as a miRNA 
SnoRNAs form a highly abundant class of non-coding RNAs in many different organisms. They 
localize to the nucleolus and guide specific modifications of rRNAs or snRNAs (Matera et al., 
2007). In the immunoprecipitated RNA of endogenous Ago complexes there are reads of about 
22 nt in length originating from snoRNAs, the most abundant one matching to snoRNA ACA45 
(Fig. 13A). The sequenced reads derive only from the 3ʼ half of the snoRNA and are conserved 
in mammals (Fig. 13B). These findings further suggest that the identified reads termed ACA45 
sRNAs are specific processing products rather than snoRNA degradation product. Consistent 
with the cloning data, the small RNAs could be validated by northern blotting and are enriched in 
Ago immunoprecipitations. Moreover, ACA45 sRNA can silence a luciferase reporter with perfect 
complementary binding sites in an Ago2 dependent manner, demonstrating that it can function 
like a miRNA.  
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3.2.2 Processing of ACA45 
The cleavage signature of the stem-loop-structured processing intermediate is different from the 
typical 2 nt 3ʼ overhangs generated by Drosha. Consistently, ACA45 sRNA can mediate 
luciferase reporter cleavage upon depletion of Drosha, suggesting that processing of ACA45 is 
microprocessor independent. Moreover, immunoprecipitated DGCR8 was not able to cleave a 
32P-labeled in vitro transcribed ACA45. However, a specific cleavage product was observed in 
the anti-DGCR8 immunoprecipitates using primary miR-27a as transcript (Fig. 16A). These 
results are supported by the analysis of the libraries from DGCR8 knockout ES cells where 
ACA45 sRNA is present (Babiarz et al., 2008).  
It was shown by northern blotting and semi-quantitative PCR that ACA45 processing requires 
Dicer (Fig. 2.18). Moreover, Dicer can process the full length ACA45 in vitro. In vivo, only a 
minor portion is processed to a small miRNA-like RNA, as shown by the analysis of total RNA in 
northern blots, where the strongest signal originates from the full-length ACA45. This 
observation is consistent with the finding that ACA45 exists as a functional snoRNA that forms 
snoRNPs with the protein factor GAR-1 (Matera et al., 2007).  
In the model described in figure 3.1A, ACA45 is transcribed and functions presumably in cajal 
bodies of human cells. However, a minor portion is transported to the cytoplasm by a so far 
unknown export receptor. In the cytoplasm, Dicer immediately processes the full-length snoRNA 
to a miRNA-like small RNA that functions in gene silencing. The finding that recombinant Dicer 
as well as Dicer-containing Ago protein complexes are capable of generating full-length ACA45 
small RNAs in vitro supports this hypothesis.  
Most snoRNAs have not been reported to be transported to the cytoplasm. However U3, U8 and 
U13 snoRNA have been shown to be associated with the phosphorylated export adaptor PHAX 
and U3 additionally to the cap-binding complex, Ran, the exportin CRM1, all involved in snRNA 
maturation, and the nucleo-cytoplasmic shuttle protein Nopp140 (Boulon et al., 2004; Leary et 
al., 2004; Watkins et al., 2007; Watkins et al., 2004). This could indicate that the capped 
mammalian pre-snoRNAs are exported to the cytoplasm. Indeed, all four precursors and the 
mature U8 were found in nucleoplasmic extracts, whereas the cytoplasmic extract contained two 
precursor forms. For U3 and U13 both the precursors and the mature snoRNAs were present in 
the cytoplasm. However, these snoRNAs are transcribed from independent transcription units. 
The primary transcripts of these genes possess an m7G cap structure. During biogenesis, the 
cap is hypermethylated to an m2,2,7G cap (m3G cap) and can be recognized by export factors 
mentioned above. A similar hint for export of other snoRNAs has not been observed yet. It would 
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be intriguing to find out if H/ACA snoRNAs, in particular ACA45 is associated with Ran or other 
export factors. Moreover, it should be analyzed if mature snoRNAs or their precursor can be 
found in the cytoplasm. 
Alternatively to cytoplasmic processing of ACA45, ACA45 is cleaved in the nucleus already and 
one half is recognized as miRNA precursor by the pre-miRNA export pathway (Fig. 3.1B). 
However, to avoid cleavage of the majority of the ACA45 pool, which is needed for classical 
snoRNA functions, a nuclear cleavage activity would have to be very inefficient or specially 
regulated, as it is for example known for microprocessor-mediated cleavage of some specific 
miRNAs (Davis et al., 2008); (Fukuda et al., 2007); (Guil and Cáceres, 2007); (Winter et al., 
2009). In the case of nuclear cleavage, only a part of ACA45 would be exported. This could 
explain the observation that only reads from the 3ʼ half of ACA45 were found in the libraries, 
although the other half folds like a typical miRNA precursor as well.  
Dicer mainly localizes to the cytoplasm but nuclear localization has been shown as well (Daniels 
et al., 2009). Therefore, it could also be possible that Dicer cleaves ACA45 in the nucleus (Fig. 
3.1B). In both cases, nuclear or cytoplasmic cleavage, it is not clear whether Dicer is the only 
nuclease or if a second nuclease cleaves ACA45 before Dicer processing as it does not 
structurally represent a classical Dicer substrate with 2 nt 3ʼ protruding ends. However, the 
involvement of another nuclease seems rather unlikely as it was observed that Dicer alone can 
cleave ACA45 in vitro (Fig. 2.17B). Indeed, it was shown that free ends are not absolutely 
required for Dicer cleavage: terminally blocked dsRNA is cleaved internally, with reduced 
kinetics. After the initial internal cleavage, normal kinetics is restored as 2-nt 3′-overhang-
containing ends become available (Zhang et al., 2004). This two-step cleavage could explain the 
processing intermediate shown in Fig. 2.17B (indicated with asterisks). After all, Dicer seems to 
be a very likely candidate to process ACA45 on its own. It has been shown that Drosha cleaves 
miRNAs co-transcriptionally, after recruiting the early spliceosome complex but before splicing 
(Ballarino et al., 2009; Kim and Kim, 2007; Morlando et al., 2008; Pawlicki and Steitz, 2008). 
Keeping in mind that Dicer might function in the nucleus, it would be interesting to see if Dicer is 
found associated to the chromatin with transcribed snoRNA. If so, this would also suggest that 
snoRNA processing does not need the mature snoRNA. However, to answer this question it is 
also possible to knock down snoRNA assembly factors such as Naf1 and analyze if ACA45 
sRNA can still be observed.  
Discussion  67 
Figure 3.1. ACA45 processing and sACA45 function in human cells 
 
 
Two simplified models of snoRNA processing are shown. (A) ACA45 is transported to the cytoplasm and 
processed by Dicer (in addition possibly by another nuclease creating a processing intermediate) to a 
miRNA-like small RNA functioning in gene silencing. (B) ACA45 is processed by nuclear Dicer to ACA45 
small RNA, transportetd to the cytoplasm and acting like a miRNA. Nuclear processing could also be 
performed by an unknown nuclease or Dicer creating a processing intermediate. The intermediate can 
then be exported to the cytoplasm, followed by a second processing step by Dicer 
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3.2.3 SnoRNA-derived miRNAs are a general mechanism of small RNA generation 
By analyzing larger data sets, several small RNAs with miRNA-like processing signatures 
originating from snoRNAs were found, namely ACA47, ACA36b, U92, HBI-100, ACA56, ACA3, 
and ACA50 (Figure 2.22). Only snoRNAs were counted with reads in at least two data sets 
between Ago1-4 where both arms of the individual stems are present. Many more candidates 
can be identified where the star sequences is not present. Consistently with the work described 
here, more miRNA-like snoRNAs have been identified in independent studies. A report 
investigating the small RNAs present in human cells describes small RNA fragments mapping to 
four box H/ACA snoRNAs (Kawaji et al., 2008) By analyzing several small RNA libraries, Taft et 
al found short RNA sequences derived from snoRNAs in human, mouse, chicken, fruit fly, 
Arabidopsis and fission yeast (Taft et al., 2009b). Analysis of the size distribution in humans 
showed that H/ACA box derived reads were about 22 nt in length whereas C/D box derived 
sRNAs were predominantly 17-19 nt and 30 nt. Moreover, they found that reads from H/ACA box 
snoRNAs are predominantly from the 3ʼ end whereas C/D box derived sRNAs are rather from 
the 5ʼ end. These findings support the hypothesis that a considerable number of snoRNAs are 
natural precursors for functional small RNAs. In a third study, it is summarized that 14 known 
box H/ACA snoRNAs encode fragments of the size of miRNAs that have been experimentally 
detected, 7 of them in this work here, three of them have already been annotated as miRNAs 
previously (Scott et al., 2009). Moreover, they get to a similar result from another point of view. 
They find 20 genomic regions encoding miRNAs that have a highly significant similarity to 
snoRNAs, both on the level of their surrounding genomic context as well a their predicted folded 
structure.  
SnoRNAs acting as miRNAs have also been found in Gardia lamblia, a unicellular and 
binucleated protozoan parasite (Saraiya and Wang, 2008). It is one of the earliest branching 
eukaryotes with many primitive features. No RNA interference has been observed in Gardia but 
analysis of the genome showed a Dicer and Ago homolog. The structure of Dicer has been 
resolved and it has been shown to cleave dsRNA in vitro and support RNAi in S. pombe Dicer 
deletion mutants. Interestingly, the genome of Giardia shows no Drosha or Exportin-5 homolog.  
Saraiya and colleagues isolated, cloned and sequenced small RNAs from Giardia and identified 
snoRNA sequences among them. One of them, miR-2, was identified as a Dicer-digested 
product from GlsR17, previously identified as a box C/D snoRNA in Giardia. Putative target sites 
for miR-2 were identified at the 3ʼ-UTRs of many variant surface protein (VSP) mRNAs. 
Expression of a reporter mRNA carrying these putative target sites was specifically inhibited by 
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miR-2 without affecting the mRNA level. Subsequent analysis also indicated the dependence of 
this inhibition on the presence of Argonaute, thus verifying the ability of a snoRNA derived 
miRNA to function in miRNA-mediated translational repression in Giardia.  
The finding of miRNA-mediated repression using snoRNA precursors in such an ancient 
organism is interesting as it is possible that snoRNAs, besides their canonical functions, may 
have become involved in gene regulation, meaning some miRNAs have evolved from snoRNAs.  
3.2.4 Orphan snoRNAs 
Using cloning and sequencing approaches, a variety of different snoRNA genes have been 
identified in the past (Bachellerie et al., 2002). However, many of these snoRNA candidates 
have not been characterized in detail and there are snoRNAs which do not contain sequences 
complementary to rRNA or any other RNA species. It is unknown whether or not these 
candidates represent functional snoRNAs. Because of lacking complementary sequences in the 
genome, these snoRNAs are called ʻorphanʼ snoRNAs. Some of them might regulate 
alternatively spliced transcripts. It has been reported that the snoRNA HBII-52 regulates 
alternative splicing of the serotonin receptor 2C via a conserved region complementary to the 
snoRNA (Kishore and Stamm, 2006). HBII-52 is a brain-specific snoRNA and its locus is 
maternally imprinted. Maternally imprinted genes are generally expressed only when inherited 
from the father. Loss of paternally expressed genes lead to the development of the Prader-Willi 
syndrome, characterized by neonatal hypertonia, failure to thrive during infancy and later obesity 
and hypogonadism. Kishore at al showed that HBII-52 is likely to bind a silencer element in exon 
Vb, increasing its inclusion in the mRNA of the serotonin receptor 2C. MRNAs lacking exon Vb 
are not functional. Interestingly, the sites of HBII-52 complementary to the serotonin receptor 2C 
are 18 nt in length. It would be interesting to analyze whether base pairing is done by a 
processed form of the snoRNA rather than by full length HBII-52. 
It is tempting to speculate that orphan snoRNAs are specifically processed to small RNAs 
functioning in gene silencing. However, it would also be intriguing to analyze if a snoRNAs can 
act both as a canonical snoRNA and as sRNA precursor. Many snoRNAs being a precursor for 
miRNAs, including ACA45, have a predicted target pseudouridinylation site. It will be interesting 
to see whether they can act indeed on both their canonical snoRNA target and their miRNA 
target. However, snoRNAs identified in Scott et al have a AGA sequence instead of a ACA box, 
indicating that they are no longer functional (Scott et al., 2009). Further analysis has to be done 
to clarify the relationship between miRNAs and snoRNAs. 
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3.2.5 tRNA processing 
Working as an adapter molecule, tRNAs decode genetic information that is translated into 
proteins by the ribosome. TRNAs are 75 – 95 nt in length and have four domains, the D-arm, the 
anticodon arm, the TψC and the acceptor stem. They are transcribed by polymerase III and the 
internal promoters constitute two discrete regions corresponding to nt 8–19 (box A) and 52–62 
(box B) of a tRNA. Nucleotides 8, 14, 18 and 19 in box A, and nt 53–56, 58 and 61 in box B are 
highly conserved among all tRNAs because of the tRNA tertiary structure (Goodenbour and Pan, 
2006). TRNA precursors have a 5ʼ and 3ʼ trailer. The 5ʼ trailer is cleaved by RNAse P and the 3ʼ 
trailer by RNAse Z, yielding a tRNA primed for addition of the CCA motif by the CCA-adding 
enzyme. The CCA nucleotide sequence is essential for amino acid attachment and interaction 
with the ribosome. Moreover, tRNAs get modified to stabilize their structure (modifications in the 
core regions) and modifications are important for codon pairing and accurate recognition by the 
cognate aminoacyl-tRNA synthetase (modifications in the anticodon loop) (Nakanishi and 
Nureki, 2005).  
In humans, there are 49 families of tRNAs (encoding for 20 amino acids plus selenocystein) 
grouped according to their isoacceptor (Lander et al., 2001). Codon degeneracy requires up to 5 
tRNAs with distinct anticodons (tRNA isoacceptors) to read codons for each amino acid. 
Moreover, there is a huge number of tRNA pseudogenes and tRNA genes having the same 
anticodon sequence but differences elsewhere in the tRNA body. The very high number of tRNA 
genes makes it difficult to annotate short reads derived from small RNA cloning to a precise 
tRNA locus. Data generated in this work indicate that tRNAs are processed into small RNAs of 
about 18-22 nt in length. At least some of them seem to derive from mature tRNAs as their 3ʼ 
end carries a CCA tail. They coimmunoprecipitate with Ago proteins, indicating that they are 
functional small RNAs rather than just random degradation products. Indeed, 
immunoprecipitated Ago complexes can cleave target RNAs with a perfect complementary site 
to specific tRNA fragments in vitro. The small tRNA fragments analyzed in this work are present 
in Dicer knock out cells and therefore it remains a mystery so far how these tRNA fragments are 
processed. However, several observations by other laboratories indicate that tRNAs can be 
endonucleolytically cleaved as stress response. In Escherichia coli (E. coli), tRNAs can be 
cleaved in response to a bacteriophage infection (Levitz et al., 1990). TRNA cleavage occurs 
during amino acid starvation in Tetrahymena and during oxidative stress in human, plant and S. 
cerevisiae. (Lee and Collins, 2005; Thompson et al., 2008; Yamasaki et al., 2009). So far, 
preliminary results (data not shown) do not show any connection between small tRNA fragments 
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associated to Ago proteins and oxidative stress. Moreover, stress induced tRNA cleavage 
occurs mainly in the anticodon loop, creating longer fragments than those observed in this work. 
Therefore, further analysis of tRNA cleavage should be concentrated on RNAse Z or RNAse P, 
which are responsible for tRNA maturation. Moreover, it should be investigated if tRNA can 
induce target cleavage in vivo and possible target sites should be identified. A general 
conclusion can not be made at this point and a more comprehensive analysis about small tRNAs 
will be performed. 
 
Material & Methods  72 
4 Material & Methods 
4.1 Material 
4.1.1 Chemicals and enzymes 
Unless stated otherwise, all chemicals were purchased from Amersham Bioscience 
(Buckinghamshire,UK), Biorad (Hercules, USA), Merck (Darmstadt, Germany), Qiagen (Hilden, 
Germany), Roche (Penzberg, Germany), Roth (Karlsruhe, Germany) and Sigma-Aldrich 
(Munich, Germany). Radioactive chemicals were provided by Perkin Elmer (Waltham, USA). 
Enzymes were delivered from New England Biolabs (Ipswich, USA) and Fermentas (Burlington, 
Canada). 
4.1.2 Plasmids 
pMIR-RNL  encodes for the Phototinus pylaris luciferase (in this work 
termed firefly) under the control of a CMV promoter and a 
Renilla reniformis luciferase (in this work termed renilla) 
under the control of a SV40 promoter. The firefly coding 
sequence is flanked by a multiple cloning site (MCS) at its 3ʼ 
end, allowing for the introduction of regulatory sequences 
into the 3ʼUTR. The plasmid carries an ampicillin resistance 
(Beitzinger et al., 2007). 
 
pBluescript KS(+)  was used for in vitro transcription (Fermentas). The 
sequence includes a polylinker sequence (MCS), antibiotic 
resistance sequence to ampicillin and an E. coli and f1 
helper phage origin of replication. The MCS is flanked by a 
T7 and a T3 promoter. 
4.1.3 Antibodies 
α-human Ago1 (4B8) monoclonal, rat hybridoma supernatant 
 (Beitzinger et al., 2007) 
α-human Ago2 (11A9)  monoclonal, rat hybridoma supernatant  
 (Rüdel et al., 2008) 
Material & Methods  73 
α-human Ago3 (5A3) monoclonal, rat hybridoma supernatant  
 (Weinmann et al., 2009) 
α-human Ago4 (6C10) monoclonal, rat hybridoma supernatant  
 (Weinmann et al., 2009) 
α-human RmC (16D2) monoclonal, rat hybridoma supernatant  
α-human Gar1 kindly provided by Witold Filipowicz 
α-HA Covance 
α-mouse Ago2 (6F4) monoclonal, rat hybridoma supernatant 
α-mouse IgG peroxidase conjugated, Sigma 
α-rat IgG peroxidase conjugated, The Jackson Laboratory 
4.1.4 Bacterial strains and cell lines 
Bacterial strains: E. coli XL1 blue 
Cell lines: HeLa 
 HEK 293T 
 Dicer +/- ES cells (Murchison et al., 2005) 
 Dicer -/-  ES cells (Murchison et al., 2005) 
4.1.5 Cell culture media 
For cultivation of the cell lines the following media were used: 
 
Normal medium: 500 ml  DMEM (PAA, Pasching, Austria) 
 10% fetal bovine serum 
 (Biochrom, Berlin, Germany) 
 1% Penicillin/Streptomycin  
  (PAA, Pasching, Austria) 
4.1.6 Buffers and solutions 
Phosphate buffered saline 130 mM NaCl 
(PBS) 774 mM Na2HPO4 
 226 mM NaH2PO4 
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1x TBE buffer 89 mM Tris pH 8.3 
 89 mM  boric acid 
 2.5 mM EDTA 
 
SDS running buffer 200 mM Glycin 
 25 mM Tris pH 7.5 
 25 mM SDS 
 
Towbin-blotting buffer 10x 192 mM Glycin 
 0.025 mM Tris 
 20% Methanol 
 
Western blotting wash buffer 300 mM Tris pH 7.5 
 150 mM NaCl 
 0.25% Tween-20 
 
Chemiluminescence 100 mM Tris pH 8.5 
detection 1.2 mM Luminol   in  10 ml 
 0.68% p-cumaric acid  in 150 µl 
  H2O2 (30%)        11 µl 
  mix all components before use 
 
HEPES 2x for Calcium 274 mM NaCl 
phosphate transfection 54.6 mM HEPES 
 1.5 mM Na2HPO4 
 
MOPS buffer 50x 1M MOPS (pH 7) 
 
EDC cross-link solution 0.13 M 1-Methylimidazole (pH 8) 
 0.16 M EDC 
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LB (lysogeny broth) media 1% (w/v) Trypton 
 1% (w/v) NaCl 
 0.5% (w/v) Yeast extract 
 
20x SSC 3 M NaCl 
 0.3 M Sodium citrate 
 adjust pH to 7.1 
 
RNA loading dye 1x 90% Formamide 
 0.025% Xylene cyanol 
 0.025% Bromophenol blue 
  in 1x TBE 
 
Protein sample buffer 5x 400 mM Tris/HCl pH 6.8 
 5 mM EDTA 
 0.01% Bromphenol blue 
 50% Glycerin 
 1% SDS 
 
DNA loading dye 5x 15 g Saccharose 
 50 ml H2O 
 0.025% Xylene cyanol 
 
Polyacrylamide gels for SDS-PAGE 
5% stacking gel 5% Acrylamide 37,5:1 
 75 mM Tris pH 6.8 
 0.1 % SDS 
 0.1 % APS 
 4 µM TEMED 
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10% separation gel 10% Acrylamide 37.5:1 
 400 mM Tris pH 8.0 
 0.1% SDS 
 0.1% APS 
 4 µM TEMED 
 
PAGE elution buffer 300 mM NaCl 
 2 mM EDTA 
 
IP wash buffer 300 mM NaCl 
 50 mM Tris pH 7.5 
 5 mM MgCl2 
 1 mM NaF 
 0.01% (v/v) NP-40 
 
Cell lysis buffer I 150 mM KCl 
 25 mM  Tris pH 7.5 
 2 mM EDTA 
 1 mM NaF 
 0.5% NP-40 
 
Cell lysis buffer II 300 mM NaCl 
 2.5mM MgCl 
 0.5% NP-40 
 20 mM Tris pH 7.5 
 
RIPA buffer 50 mM Tris 
 500 mM NaCl 
 1%  NP-40 
 0.5% Sodium deoxycholate 
 0.1% SDS 
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Gradient buffer 150 mM KCl 
 25 mM Tris (pH 7.4) 
 2 mM EDTA 
 
Protease K buffer, 2x 300 mM NaCl 
 200 mM Tris pH 7.5 
 25 mM EDTA 
 2% SDS 
 
50x Denhardtʼs solution 1% Albumin fraction V 
 1% Polyvinylpyrrolidon K30 
 1% Ficoll 400 
 
Hybridizitation solution 7.5 ml 20x SSC 
 21.0 ml 10% SDS 
 0.6 ml 1 M Na2HPO4 pH 7.2 
 0.6 ml 50x Denhardtʼs solution 
 
Renilla buffer 2.2 mM EDTA 
 220 mM K2PO4 pH 7.2 
 0.44 mg/ml BSA 
 1.1 M NaCl 
 1.3 mM NaN3 
 1.43 µM Coelenterazine (P.J.K.,  
  Kleinblitterdorf, Germany) 
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Firefly buffer 470 µM D-luciferin (P.J.K., 
  Kleinblitterdorf, Germany) 
 530 µM ATP (P.J.K., 
  Kleinblitterdorf, Germany) 
 270 µM Coenzyme A (P.J.K., 
  Kleinblitterdorf, Germany) 
 20 mM Tricine 
 5.34 mM MgSO4 pH 7.2 
 0.1 mM EDTA 
 33.3 mM DTT 
 
Denaturing polyacrylamide gels for sample purification 
using the SequaGel®-Kit from National Diagnostics (Atlanta, USA). 
12.5% 29 ml concentrate 
 25 ml diluent 
 6 ml  buffer 
 500 µl Ammonium persulfate (APS) 
 100 µl TEMED 
 
Denaturing polyacrylamide gels for northern blotting 
12% 25.2 g Urea 
 18 ml Acrylamide (40%; 19:1) 
 1.2 ml  MOPS-NaOH (pH 7) 1M 
 360 µl APS 
 21 µl TEMED 
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4.2 Methods 
4.2.1 Molecular biological methods 
4.2.1.1 General methods 
Any less detailed descriptions of molecular biological standard methods (DNA/RNA gel-
electrophoresis, -extraction, -precipitation and the determination of concentrations of nucleic 
acids, PCR, etc.) were performed as described in Sambrook et al. (Sambrook, 1989) or 
according to the manufacturers' instructions, respectively. There, one can also find the 
composition of not listed buffers and solutions. 
The isolation of plasmid-DNA from E. coli was carried out by using the ‚Plasmid MiniKit I®ʼ 
(Omega BioTek, Darmstadt, Germany) or the ‚NucleoBond® XtraMidiʼ-Kit (Macherey Nagel, 
Düren, Germany), respectively. For the elution of DNA fragments from agarose gels, the 
NucleoSpin®-Kit (Macherey Nagel, Düren, Germany) was used. 
4.2.1.2 Cloning of 3ʼUTRs from genomic DNA into pMIR-RNL 
pMIR-RNL miRNA reporter plasmids which express the firefly luciferase ORF fused to a 
cleavage site complementary to a small RNA or a regulatory 3ʼUTR sequence and renilla 
luciferase as a transfection control were generated from pMIR-REPORT (Ambion) as described 
in Höck et al. (Höck et al., 2007). The following DNA oligonucleotides containing a sequence 
perfectly complementary to miR-19b and snoACA45 5ʼ were annealed, digested with SacI and 
NaeI and inserted into the SacI and NaeI restriction sites of the reporter plasmid: miR-19b 5ʼ-  
CGCTGAGCTCATCGCCACCTTGTTTAAGCCTCAGTTTTGCATGGATTTGCACAATTAGACCT
ACGCACTCCAGGCCGGCTCGC -3ʼ and  
GCGAGCCGGCCTGGAGTGCGTAGGTCTAATTGTGCAAATCCATGCAAAACTGAGGCTTAAA
CAAGGTGGCGATGAGCTCAGCG -3ʼ; snoACA45: 5ʼ-  
CGCTGAGCTCATCGCCACCTTGTTTAAGCCCAAGACCTGTTCTATCTACCTTATTAGACCTA
CGCACTCCAGGCCGGCTCGC -3ʼ and 5ʼ-  
GCGAGCCGGCCTGGAGTGCGTAGGTCTAATAAGGTAGATAGAACAGGTCTTGGGCTTAAAC
AAGGTGGCGATGAGCTCAGCG -3ʼ. 
3ʼUTRs were amplified by polymerase chain reaction (PCR). As template, genomic DNA of 
HEK293 cells was used. PCR amplification was performed by the Phusion™ polymerase 
(Finnzymes, Espoo, Finland). PCR products were cloned into the reporter plasmid pMIR-RNL. 
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4.2.1.3 RNA Extraction from cultured cells 
a) Total RNA extraction (mRNA and miRNAs) 
Extraction of RNA was performed following the TriFast® protocol (Peqlab, Erlangen, 
Germany). Briefly, cells were homogenized by pipetting up and down several times in an 
appropriate amount of TriFast. Samples were incubated for a few minutes at room 
temperature to let nucleoprotein complexes dissociate. 200 µl chloroform per 1 ml TriFast 
were added, the samples mixed for 20 seconds and centrifuged for 20 minutes at full speed 
in a desk top centrifuge resulting in the dissociation of organic and aqueous phase. The 
upper phase (approx. 500 µl) was pipetted into a new sterile reaction tube containing 1 ml 
isopropanol. RNA was precipitated at -20°C. After pelleting the RNA for 15 minutes by 
centrifugation at full speed, isopropanol was removed thoroughly and the pellet washed with 
80% Ethanol. After pelleting and removing the Ethanol the RNA was air-dried for 5 minutes 
and was dissolved at 70°C in an appropriate amount of ddH2O. 
 
b) RNA exraction of immunopurified complexes and input samples 
Cells were usually lysed in 1ml lysis buffer per 15 cm plate. For input samples, usually 100 µl 
lysate (generally 1/10 of lysate used for IP) was digested in 200 µl 2x proteinase K buffer 
containing 40 mg Proteinase K. RNA from immunopurified samples was directly isolated 
from antibody coupled beads by adding 200 µl 2x proteinase K buffer containing 40 mg 
Proteinase K. Proteinase K digestion was performed for 20 minutes at 65°C, followed by two 
times phenol/chloroform/isoamylalcohol extractions. For subsequent RNA precipitation, the 
aqueous phase was mixed with three volumes (miRNAs) or two volumes (mRNAs) of 
absolute ethanol and incubated at -20°C. After pelleting the RNA for 30 minutes by 
centrifugation at 17ʼ000g, isopropanol was removed thoroughly and the pellet was air-dried 
for 5 -10 minutes. RNA was dissolved at 70°C in an appropriate amount of ddH2O. 
4.2.1.4 Ago complex purification 
HEK293 cells were lysed in cell lysis buffer II and centrifuged at 10,000 g for 10 min at 4°C. For 
immunoprecipitation of endogenous Ago complexes, 100 µl Protein G Sepharose (GE 
Healthcare) was washed with PBS and incubated with 10 µl anti-Ago1 (4B8), anti-Ago2 (11A9), 
anti-FLAG (3H3), or anti-GST at 4°C with gentle agitation overnight. After several wash steps 
with PBS, beads were incubated with HEK293 cell lysate of 6 x 15 cm plates for 3 h. Anti-Ago1-
coated beads were extensively washed with lysis buffer II containing 300 mM NaCl followed by a 
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wash with PBS. Anti-Ago2-coated beads were washed five times using RIPA buffer. RNA was 
isolated with 40 mg Proteinase K in 200 µl Proteinase K buffer followed by Phenol/Chloroform 
extraction and Ethanol precipitation. For immunoprecipitation of FLAG-HA-tagged Ago 
complexes, cell lysate from two 15 cm dishes were incubated with 20 µl FLAG M2 agarose 
beads (Sigma) for 2 h at 4°C with rotation. Beads were extensively washed and 
coimmunoprecipitated RNA was extracted as described above.  
4.2.1.5 RNA polyacrylamide gel electrophoresis 
For the detection of RNA species (miRNAs, mRNAs) denaturing RNA polyacrylamide gel-
electrophoresis was performed using the SequaGel® System Kit (National Diagnostics, Atlanta, 
USA) or MOPS based urea gels according to Hamilton et al. (Pall and Hamilton, 2008). The 
acrylamide concentration was between 8 and 15%. Before loading, the samples were provided 
with 2x dye and denatured for 5 min at 95°C. The gel was pre-run for 10-15 min at 400 V. 0.5-1x 
TBE or 0.5x MOPS (for MOPS containing gels) was used as running buffer. Samples were 
loaded after rinsing each pocket with buffer and the gel was run 500 V. 
4.2.1.6 Northern blotting 
After adding formamide loading dye, the RNA was separated by electrophoresis usually on a 
12% denaturing polyacrylamide gel and transferred to Hybond-N membrane (Amersham 
Bioscience, Buckinghamshire, UK) by semidry blotting for 30 min with 20 V. H2O was used to 
prewet three sheets of Whatman, the membrane and another three sheets of Whatman on top of 
the gel. After blotting was completed, the damp membrane was removed and placed with RNA 
side face up on top of a Whatman paper saturated in freshly prepared crosslinking EDC solution. 
Wrapped in Saran the membrane was incubated for 1 h at 50 °C. After crosslinking the 
membrane was rinsed in excess RNase-free distilled water and dried. Prehybridization was 
performed in 5x SSC; 20 mM Na2HPO4, pH 7.2; 7% SDS and 1x Denhardt's solution for 1 h at 
50°C, before a 5'-32P-labeled probe (see below) was added for hybridization for 4 h up to 
overnight at 50°C. Subsequently, the membrane was washed in 10-min intervals twice with 5x 
SSC and 1% SDS and once with 1x SSC and 1% SDS. Exposure to Kodak BioMax MS films 
was performed with an intensifying screen (Kodak, Stuttgart, Germany) at –80°C.  
For northern probe preparation, 10 pmol of synthetic DNA-oligonucleotides (Metabion, 
Martinsried, Germany) or 2ʼOMe-oligonucleotides reverse complementary to the appropriate 
miRNA were radiolabeled in a T4-Polynucleotide kinase (Fermentas, Burlington, Canada) 
reaction in the presence of [γ-32P]-ATP (GE Healthcare, Munich, Germany) according to 
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standard protocols. Subsequently, the probe was purified by gel filtration using MicroSpin G-25 
columns (Amersham Bioscience, Buckinghamshire, UK). 
The following probes for northern blotting were used: 5ʼ- AAGACCTGTTCTATCTACCT -3ʼ for 
sACA45, 5ʼ- TGATGCTCTACCGACTGAGCTATCCGGGC -3ʼ for Lys tRNA, 5ʼ- 
TGGTGCCGTGACTCGGA -3ʼ for tRNA HIS 3ʼ, 5ʼ- ATGGTGTCAGGAGTGGGA -3ʼ for tRNA 
LEU 3ʼ. 
4.2.1.7 Dicer & DGCR8 cleavage assay 
In vitro transcribed pri-27a substrate used in this study was described previously (Landthaler et 
al., 2004; Meister et al., 2005). The template for pre-27a transcription was created by annealing 
the following primers: 5ʼ-  
TTAATACGACTCACTATAGCTGAGGAGCAGGGCTTAGCTGCTTGTGAGCAGGGTCCACACC
AAGTCGTGTTCACAGTGGCTAAGTTCCGCCCCCCAGC -3ʼ and 5ʼ- 
GCTGGGGGGCGGAACTTAGCCACTGTGAACACGACTTGGTGTGGACCCTGCTCACAAGCA
GCTAAGCCCTGCTCCTCAGCTATAGTGAGTCGTATTAA. ACA45 was cloned from genomic 
DNA using the primers 5ʼ- ACGAGCTCCTGGAGACTAAGAAAATAGAGTCCTTGA and 5ʼ-
ACGGTACCTGCTGTTGGTAGATAAGTAGGTCTTGAA, digested with SacI and KpnI, and 
inserted into the SacI and KpnI restriction sites of the pBluescript. Plasmid was linearized using 
the KpnI restriction site and transcribed in vitro. Briefly, 8 μl 5x NTP mix (A/C/G/U = 5/5/8/0.1 
mM), 8 μl 5x T7 buffer, 0.2 μl DTT (1M), 1 μl T7 RNA polymerase (Fermentas), 5 μl (α-32P)-UTP 
(3000Ci/mmol) and 1 μl PCR product or 3 μl linearized plasmid in a 40 μl reaction was incubated 
for 2 h at 37°C. After adding RNA sample buffer, RNA was purified by 8% denaturing RNA-
PAGE, detected by autoradiography, gel eluted over night and recovered by Ethanol 
precipitation. The construction of human FLAG-HA-Ago1, FLAG-HA-Ago2, and FLAG-HA-Dicer 
has been reported earlier (Meister et al., 2005). FLAG-HA-DGCR8 was purchased from 
Addgene. Immunoprecipitations were performed as described earlier. For cleavage activity 
assays, 10 μl of Ago or Dicer complex-containing anti-FLAG beads were incubated in 20 μl PBS 
containing 5 mM ATP, 7.5 mM MgCl2, 10 U/ml RNasin (Promega) and RNA (2Bq/cm2) at 37°C. 
The reaction was stopped by adding 200 μl proteinase K buffer containing proteinase K (0.2 
mg/ml). RNA was isolated by Phenol/Chloroform extraction, precipitated with Ethanol and 
analyzed by 8% or 12% denaturing RNA-PAGE. Signals were detected by autoradiography.  
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4.2.1.8 RISC cleavage assay 
For mapping RNA cleavage, a transcript was generated using the following primers: 5ʼ- 
TAATACGACTCACTATAGAACAATTGCTTTTACAG -3ʼ as T7 primer, 5ʼ- 
ATTTAGGTGACACTATAGGCATAAAGAATTGAAGA -3ʼ as SP6 primer, 5ʼ- 
GAACAATTGCTTTTACAGATGCACATATCGAGGTGAACATCACGTACGTGGTGCCGTGACTC
GGATCGGTTGGCAGAAGCTAT 3ʼ for tRNA HIS and 5ʼ-  
GAACAATTGCTTTTACAGATGCACATATCGAGGTGAACATCACGTACGATGGTGTCAGGAGT
GGGATCGGTTGGCAGAAGCTAT 3ʼ for tRNA LEU and 5ʼ-  
GGCATAAAGAATTGAAGAGAGTTTTCACTGCATACGACGATTCTGTGATTTGTATTCAGCCC
ATATCGTTTCATAGCTTCTGCCAACCGA for the sequence comlementary to the 
oligonucelotide with the specific cleavage sequence. Regions complementary to tRNA fragments 
are underlined. The following PCR reaction was performed: 37 μl H2O, 10 μl 5x buffer 
(Finnzymes), 1 μl dNTPs (10 mM), 0.3 μl SP6 primer (100 μM), 0.3 μl T7 primer (μM), 1 μl 
primer with specific cleavage sequence, 1 μl primer comlementary to the specific cleavage 
sequence and 1 μl Phusion polymerase (Finnzyme). 
PCR products were in vitro tanscribed using the following reacion: 20 μl 5x NTP mix (A/C/G/U = 
5/5/8/2 mM), 20 μl 5x T7 buffer, 0.5 μl DTT (1M), 2 μl T7 RNA polymerase (Fermentas) and 5 μl 
PCR product in a 100 μl reaction were incubated for at least 2 h at 37°C. After adding RNA 
sample buffer, RNA was purified by 8% denaturing RNA-PAGE, detected by UV shadowing, gel 
eluted over night and recovered by Ethanol precipitation.  
For RISC activity assays, substrates were 32P-cap labelled as follows: 1.5 μl (α-32P)-GTP 
(3000Ci/mmol), 2 μl 10x buffer (0.4 M Tris pH 8.0, 60 mM MgCl2, 100 mM DTT, 20 mM 
spermidine), 0.25 μl RNasin (Promega), 1 μl S-adenosyl-Met (500 μM), 1 μl DTT (1M), 1 μl 
Guanyltransferase and ½ RNA from the 20 μl in vitro transcription reaction was incubated for 3 h 
at 37°C. After adding RNA sample buffer, RNA was purified by 8% denaturing RNA-PAGE, 
detected by autoradiography, gel eluted over night and recovered by Ethanol precipitation.  
10 μl of Ago complex-containing anti-FLAG beads were incubated in a 25 μl reaction containing 
5 nM target RNA, 1 mM ATP, 0.2 mM GTP, 10 U/mL RNasin (Promega), 100 mM KCl, 1.5 mM 
MgCl2 and 0.5 mM DTT for 1.5 h at 30°C. RNA was isolated as described above and analyzed 
by 8% denaturing RNA-PAGE. Signals were detected by autoradiography using BioMax MS film 
(Kodak) and an intensifying screen (Kodak). 
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4.2.1.9 Reverse transcription - cDNA synthesis 
RNA was isolated as described in “RNA Extraction from cultured cells”, b) and dissolved in 12 μl 
H2O. RNA was first treated with DNaseI to remove DNA contaminations using the following 
reaction mix: 12 μl RNA, 1.5 μl DNaseI buffer (Fermentas), 1 μl DNaseI (Fermentas) and 0.5 µl 
RiboLock (Fermentas). DNaseI digest was performed for 30 minutes at 37°C. Afterwards the 
enzyme was inactivated for 10 minutes at 70°C and reaction was cooled on ice. Then, cDNA 
synthesis was performed in a final 30 μl reaction using “First Strand cDNA Synthesis-Kit”” from 
Fermentas (Burlington, Canada), according to the manufacturerʼs protocol. For quantitative real-
time PCR (qRT PCR), cDNA from immunopurified samples were adjusted to a final volume of 40 
μl, total RNA to a final volume of 60 μl. 1 μl cDNA in 10.5 μl H2O was used per well for a 25 μl 
PCR reaction.  
4.2.1.10 Poly(A) tailing of miRNAs for qRT-PCR 
In order to detect miRNAs in a qRT-PCR reaction the mature miRNAs have to be modified as 
described in Hurteau et al. (Hurteau et al., 2006). RNA was extracted using Trifast followed by 
DNaseI digestion as described above. MiRNAs were subsequently poly(A) tailed using the 
“Poly(A) Tailing-Kit” from Ambion with the follwing reaction: 5 μl DNaseI treated RNA, 5 μl 5x E. 
coli poly(A) polymerase I (E-PAP) buffer, 2.5 μl 25mM MnCl2, 2.5 μl 10mM ATP, 1 μl E-PAP and 
9 μl nuclease free H2O.  
Reverse transcription was performed with 10 μl of the E-PAP treated total RNA using the “First 
Strand cDNA Synthesis-Kit” from Fermentas. Instead of the random-primer mix provided, 1 μl l 
of a 100 mM universal reverse transcription primer (URT primer; 5ʼ- 
AACGAGACGACGACAGACTTTTTTTTTTTTTTT 3ʼ) was used. This primer comprises a poly(T) 
and a unique URT primer sequence and anneals to poly(A) tails. cDNA was amplified by qRT-
PCR using Mesa Green qPCR MasterMix Plus (Eurogentec), specific forward primers for the 
small RNA (5ʼ- AAGGUAGAUAGAACAGGUCUUG for ACA45, 5ʼ- 
TCCCTGAGACCCTAACTTGTGA for miR-125b, and 5ʼ- ACACATCCAAATGAGGCG for 7SK) 
and the URT sequence as the universal reverse PCR primer. The PCR products were analyzed 
by 4% agarose gel electrophoresis. 
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4.2.1.11 qRT-PCR 
Quantitative PCR analysis was performed using a BioRad (Hercules,USA) real-time detection 
system and the Mesa Green qPCR MasterMix Plus (Eurogentec, Cologne, Germany).  
The qRT-PCR reactions were set up as 25 μl reactions: 12.5 μl MESA GREEN qPCR kits for 
SYBR® Assay, 0.5 μl, forward RT-primer (10 μM), 0.5 μl reverse RT-primer (10 μM), 11.5  μl 
cDNA (diluted, see chapter 5.1.9) 
4.2.1.12 Generation of small RNA libraries for 454 sequencing 
Small RNA cloning was carried out by Vertis Biotechnology (Weihenstephan, Germany) and has 
been described earlier (Tarasov et al., 2007). Without any size fractionation, extracted Ago-
associated RNAs were poly(A) tailed using poly(A) polymerase, and an adaptor was ligated to 
the 5ʼ- phosphate of the miRNAs: (5ʼ end adaptor [43 nucleotides]: 5ʼ-
GCCTCCCTCGCGCCATCAGCTNNNNGACCTTGGCTGTCACTCA -3ʼ ). NNNN represents a 
ʻʻbarcodeʼʼ sequence. Next, first-strand cDNA synthesis was performed using an oligo(dT)- linker 
primer and M-MLV-RNase H reverse transcriptase (3ʼ end oligo [dT] linker primer [61 bases]: 5ʼ- 
GCCTTGCCAGCCCGCTCAGACGAGACATCGCCCCGC[T]25 -3ʼ ). The resulting cDNAs were 
PCR amplified in 22 cycles using the high-fidelity Phusion polymerase (Finnzymes). The 120–
135 bp amplification products were confirmed by polyacrylamide gel electrophoresis analysis. 
Both cDNA pools were mixed in equal amounts and subjected to gel fractionation. The 120–135 
bp fraction was electroeluted from 6% polyacrylamide gels. After isolation with Nucleospin 
Extract II (Macherey and Nagel), cDNA pools were dissolved in 5 mM Tris (pH 8.5) with a 
concentration of 10 ng/ml and used in single-molecule sequencing. Massively parallel 
sequencing was performed by 454 Life Sciences (Branford, USA) using the Genome Sequencer 
20 system as well as MWG Biotech (Germany). The complete sequencing data is available at 
the Gene Expression Omnibus (GEO, Accession number: GSE13370.) 
4.2.1.13 Generation of small RNA libraries for Solexa sequencing 
The protocol was adapted from Pfeffer et al. (Pfeffer, 2007). 
 
Adenylation of 3ʼAdapter 
For the adenylation of the 3ʼ adapter, 5 μl phosphorylated adapter (500 μM; 5ʼ- 
TCGTATGCCGTCTTCTGCTTG-3ʼ) and 75 μl of the antisense adapter (100 μM; 5ʼ- 
CTGGAATTCGCGGTTAAATATAGTGCAGT) were mixed with 0.25 μl Tris pH 7.5 (2 M), 5 μl 
NaCl (0.3 M), 10 μl EDTA (1 mM) and 19.75 μl H2O. The two oligonucleotides were annealed by 
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heating at 95°C for 3 min and cooling on ice for 5 min. The solution was then brought to 215 μl 
total volume containing 40 μl MOPS (0.2 M), 2 μl MgCl2 (1 M), 20 μl DTT (0.1 M), 20 μl ATP 
(100 mM) and 18 μl concentrated T4 DNA Ligase (30U/μl, Fermentas). The total mixture was 
incubated for 24h at 25°C. Samples were then loaded on a 18% denaturing 
acrylamide/bisacrylamide gel, and the band corresponding to the adenylated oligonucleotide was 
excised and eluted in elution buffer after visualization by ultraviolet (UV)-shadowing. After RNA 
preciptiation, pellet was dissolved in water and adjusted to a concentration of 50 μM.  
 
Labelling of the 19nt and 24nt markers 
The 19nt and 24nt containing PmeI restriction sites (5ʼ- CGUACGCGGGUUUAAACGA -3ʼ and 
5ʼ- CGUACGCGGAAUAGUUUAAACUGU -3ʼ) were prepared as follows: 
1 μl RNA marker (20 μM), 2 μl polynucleotide kinase (PNK) buffer (10x, Fermentas), 14.5 μl 
H2O, 2 μl [γ-32P]-ATP and 0.5 μl PNK (Fermentas) were incubated for 20 min at 37°C, loaded on 
a 18% denaturing acrylamide gel, excised and eluted in elution buffer over night after 
visualization by autoradiography. After Ethanol precipitation, the pellet was dissolved in 20 μl of 
water.  
 
Isolation of small RNA fraction and adapter ligation 
The RNA extracted from Ago immunoprecipitations was spiked with radiolabelled 
oligonucleotides of 19 and 24 nt in size (1 μl of a freshly made 20 nM stock). After denaturation 
for 30 sec, RNA was loaded onto a 15% denaturing RNA-PAGE and exposed to a 
phosphoimaging screen. Gel pieces of 19-24 nt in size were sliced out, gel eluted and 
precipitated.  
For ligation of the 3ʼ adapter, the RNA pellet was dissolved in 9 µl H2O and mixed with 2 μl 10x 
ligation buffer (0.1 M MgCl2, 0.1 M 2-Mercaptoethanol, 0.5 M Tris pH 7.6 and 1 mg/ml acetylated 
bovine serum albumin), 6 μl DMSO (50%) and 1 μl 3ʼ Adapter (50 μM) and denatured for 30 sec 
at 90°C. After cooling on ice, 2 μl truncated T4 RNA ligase 2 (Rnl2, New England Biolabs) were 
added, and the mixture was incubated at 37°C for 1 h. The reaction was stopped by adding RNA 
sample buffer and samples were separated on a denaturing 15% acrylamide gel. The ligation 
product was visualized after phosphorimaging of the gel for 45 min and was excised. After gel 
elution in 300 μl 0.3 M NaCl in siliconized tubes, the RNA was subsequently precipitated. 
For ligation of the 5ʼ adapter, the RNA-pellet was dissolved in 8.6 μl H2O, 2 μl 10x ligation buffer 
(0.1 M MgCl2, 0.1 M 2-Mercaptoethanol, 0.5 M Tris pH 7.6 and 1 mg/ml acetylated bovine serum 
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albumin), 0.4 μl ATP (100 mM), 6 μl DMSO (50%) and 1 μl 5ʼ adapter RNA oligo (100 μM; 5ʼ 
GUUCAGAGUUCUACAGUCCGACGAUC 3ʼ). After denaturation of the RNA for 30 s at 90°C 
and cooling on ice, 2 μl of T4 RNA ligase (New England Biolabs) were added and the sample 
was incubated at 37°C for 1 h. The reaction was stopped by addition of 1 volume of formamide 
loading solution, and samples were separated on a denaturing 15% acrylamide/bisacrylamide 
gel. The ligation product was collected as in the previous step after phosphorimaging of the gel 
and eluted overnight in 300 μl 0.3 M NaCl in siliconized tubes supplemented with 1 μl of a 100 
mM solution of the reverse transcription primer (5ʼ-CAAGCAGAAGACGGCATACGA-3ʼ). The 
RNA was subsequently precipitated. 
 
Reverse Transcription, PCR amplification and PmeI digestion 
The precipitated RNA was dissolved in 5.6 μl H2O and denatured by heating for 30 sec at 90°C. 
Then, 1.5 μl of 0.1 M DTT, 3 μl of 5x first-strand buffer and 4.2 μl of 2 mM dNTPs were added, 
the reaction was incubated for 3 min at 50°C and 0.75 μl of reverse transcriptase (200 U/μl 
Superscript III, RNase H [-] M-MLV reverse transcriptase, Invitrogen) were added. The reaction 
was carried out at 50°C for 45 min. The remaining RNA was hydrolyzed by adding 40 μl of 150 
mM KOH/20 mM Tris and incubating 10 min at 90°C and the solution was neutralized by 
addition of 40 μl of 150 mM HCl to obtain a pH between 7.0 and 9.5.  
To amplify the cDNA from previous step, 10 μl of 2 mM dNTPs, 10 μl of 10x PCR buffer, 1 μl of 
100 mM 3ʼ primer (same as RT primer), 1 μl of 5ʼ primer (5ʼ- 
AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA 3ʼ), 67 μl of water, and 1 
μl of Taq DNA polymerase (5U/μl) were added to 10 μl of cDNA, and cycling was performed with 
the following parameters: 45 s at 94°C , 85 s at 50°C , and 60 s at 72°C for 25 cycles. An aliquot 
of 5 µl of PCR was taken after 15, 20, and 25 cycles. The PCR aliquots were visualized after 
loading on a 3% NuSieve agarose gel (Cambrex) using a 25 bp DNA ladder (Invitrogen) as a 
size marker to determine the number of PCR cycles corresponding to the linear range of 
amplification. A new PCR using the same conditions and the correct number of cycles was then 
performed. After amplification, NaCl was added to a final concentration of 0.3 M, the DNA was 
extracted with phenol and phenol/chloroform and precipitated with ethanol.  
To get rid of the cloned size markers, the pellet was dissolved in 10 μl 10x NEB buffer 4.88 μl 
water, and 2 μl PmeI and incubated at 37°C for 2 h. The digested product was extracted once 
with phenol/chloroform after addition of NaCl to a final concentration of 0.3 M and once with 
chloroform and precipitated with ethanol. The pellet was dissolved in 30 μl 1x PCR buffer and 
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loaded on a 3% NuSieve agarose gel. After migration, the band was visualized on a UV table, 
and cut out. The gel slice was weighted, at least 1 volume of 0.4 M NaCl was added and placed 
at 65°C for 5 min. The DNA was then extracted once with phenol pH 8 previously heated to 
65°C, once with phenol/chloroform, and once with chloroform. After addition ethanol, the PCR 
product was precipitated and the pellet was dissolved in 50 μl H20, ready for sequencing.  
4.2.2 Cell biological methods 
4.2.2.1 Culturing of mammalian cells 
Mammalian cell lines were cultured in Dulbeccoʼs Modified Eagleʼs Medium (DMEM, PAA, 
Pasching, Austria) at 37°C and 5% CO2 in culture plates of different sizes. The medium was 
supplied with 10 % (v/v) fetal bovine serum (FBS, Biochrome, Berlin, Germany) as well as 1% 
(v/v) penicillin/streptomycin (PAA, Pasching, Austria). To split the cells, medium was aspirated 
off, cells were washed once with PBS (pH 7.5) and detached by Trypsin-EDTA (PAA, Pasching, 
Austria) treatment. 
4.2.2.2 Calcium Phosphate transfections 
If not co-transfected with 2'OMe-miRNA-inhibitor, plasmids were transfected using Calcium 
Phosphate transfection methods. Approximately 5h prior to transfection cells were plated at 30% 
confluency. Per 15 cm dish 5-20 μg plasmid DNA was diluted in 1075 μl H2O and 153μl 2M 
CaCl2. 1250 μl 2× HEPES-buffered saline (274 mM NaCl, 1.5 mM Na2HPO4, 54.6 mM HEPES-
KOH pH 7.1) was added drop-wise under gentle agitation. The transfection solution was then 
sprinkled onto the cells. Medium was changed 1 d post-transfection and cells were harvested 2d 
post-transfecion. 
4.2.2.3 siRNA transfections 
For knockdown experiments siRNAs were transfected with Lipofectamine RNAiMax (Invitrogen) 
according to the manufacturerʼs protocol 5d prior to harvest of the cells or 4d prior to 
cotransfection of pMIR-RL 3ʼUTR and 2'-OMe-miRNA-inhibitor. The following siRNAs were used: 
5ʼ- AAGTCACGAAGCCTACTCGTT -3ʼ and 5ʼ- CGAGTAGGCTTCGTGACTTTT -3ʼ for Drosha, 
5ʼ- CTTGCTGAATACTTGGTCCTT -3ʼ and 5ʼ- GGACCAAGTTCAGCAAGTT -3ʼ for Dicer and 5ʼ- 
GCACGGAAGTCCATCTGAATT -3ʼ and 5ʼ- TTGTCTTGCATTCGACTAATT -3ʼ for Ago2. 
Knockdowns were validated by quantitative real-time PCR. 
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4.2.2.4 2ʼ OMe transfections 
If not used for Luciferase assys and not cotransfected with plasmids, 2ʼ OMe-miRNA-inhibitors 
were transfected with Lipofectamine RNAiMax (Invitrogen) according to the manufacturers 
protocol 2 d prior to harvest of the cells. The following 2ʼ OMe-miRNA-inhibitors were used: 5ʼ- 
AAGACCTGTTCTATCTACCTT 3ʼ for sACA45 and 5ʼ- GCAAGGGCGAATGCAGAAAATAT 3ʼ for 
BART2. BART2 is a miRNA derived from the Epxtein-Barr virus and used as a control for 
unspecific effects caused by the 2ʼ OMe-oligonucleotides. 
4.2.2.5 Cotransfection of 2ʼ OMe and luciferase reporter constructs 
The day before transfection, cells were plated subconfluently on a 48-well plate. Co-transfection 
for luciferase assays were performed with 50 ng pMIR-RL 3'UTR and 20 pmol 2'OMe-miRNA-
inhibitor per 2x104 cells in a 48-well plate using Lipofectamine 2000 (Invitrogen, Paisley, UK).  
4.2.2.6 Luciferase assays 
Luciferase activity was measured 24 h post transfection using a dual luciferase reporter system 
as described by the manufacturer (Promega). Firefly luciferase expression was normalized to 
Renilla luciferase expression. Error bars are derived from four individual experiments.  
4.2.2.7 Western blotting 
For western blotting, protein sample buffer was added to lysates or the immunoprecipitates and 
the precipitated proteins were analyzed by SDS-PAGE followed by semidry western blotting 
using 1x Towbin blotting buffer. 
4.2.2.8 Sucrose density analysis 
For complex purification and co-immunoprecipitations, HEK 293 cells were lysed in cell lysis 
buffer I containing 0.5 mM dithiothreitol and protease inhibitors (Roche, Penzberg, Germany) 
and centrifuged at 10,000g for 10 min at 4°C. For fractionations, gradients from 15% (w/v) to 
55% (w/v) sucrose in 150 mM KCl, 25 mM Tris (pH 7.4) and 2 mM EDTA were used. Lysates 
were separated by centrifugation at 30,000 r.p.m. for 18 h in an SW41 rotor at 4°C. To determine 
indicated S values, catalase (11S), apoferritin (17S) and thyroglobin (19S) were used. For the 
analysis of RNA-dependent interactions, extracts were preincubated with 100 mg/ml RNase A 
(Qiagen, Hilden, Germany) at 4°C for 1 h. 
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4.2.2.9 Computational methods for 454 data analysis 
A total of 64733 reads was obtained by deep sequencing the RNA that immunoprecipitated with 
Ago1 and Ago2. Of this, 20834 belonged to the Ago1 set and 43899 to the Ago2 set. Upon 
removal of adapters, the sequences shorter than 17 nt were discarded, resulting in 20448 and 
42604 reads in Ago1 and Ago2 sets, respectively. These reads were mapped to human genome 
(hg 18, UCSC database [Karolchik et al., 2003]) using NCBI blastn (Altschul et al., 1990) with 
the minimum word length set to 7. The mapping with the best E value was associated with each 
read. The only mismatches allowed were the first nt at the 50 end or the last three nt at the 30 
end of the read. In case a read mapped with the same E value to several locations, they were all 
taken into consideration. The genomic loci of best matches were annotated us- ing the tables 
from UCSC database (Karolchik et al., 2003). A read was anno- tated as a DNA repeat 
(including LINE, SINE, LTR) only if the genomic locus it mapped to had no other annotation. For 
purposes of identification of known and novel miRNAs, reads from the Ago1 and Ago2 libraries 
were combined and mapped to the human genome us- ing NCBI megablast with the following 
options:  mappings (full length, 100% identity) were retained. These were used as input to 
miRDeep, an algorithm designed for the discovery of Dicer substrates such as miRNAs from 
deep sequencing data (Friedla ̈ nder et al., 2008). The algorithm intersects the mappings with 
local genomic sequence to identify potential Dicer hairpin substrates. These are then scored 
according to the distribution of posi- tions and frequencies of the reads mapped to the individual 
hairpin, using Bayes- ian statistics. The energetics and stability of the hairpins and the cross-
species conservation of the seed sequence also contribute to the score. Human snoRNA 
sequences were downloaded from snoRNABase (Lestrade and Weber, 2006).  
For conservation analysis of human ACA45, the sequence was obtained at the snoRNABase 
(http://www.snorna.biotoul.fr/). The ACA45 mouse, rat, and dog homologs were identified by 
mapping the human sequence against each genome, retaining only unambiguous matches. 
Subsequently, a number of deep sequencing data sets were mapped to the ACA45 homologs. 
Each data set was mapped to the homolog of the species from which the data set originated, 
and only perfect matches were retained. The origin of the different data sets is indicated in the 
text.  
To map the total of 17362367 sequence reads obtained by sequencing Ago1–4 IP using Solexa 
technology to the genome, we used the locally devel- oped suffix array-based tool (to be 
published elsewhere). Candidate snoRNAs with miRNA-like processing were selected if the 
combined Ago1–4 data set contained reads mapping to both strands of a hairpin and if these 
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reads represented more than 85% of all reads mapping to a given snoRNA.  
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Abbreviations 
3ʼ UTR 3ʼ untranslated region 
Ago Argonaute 
CasiRNA cis-acting small interfering RNA 
Dcl Dicer-like 
Dcr Dicer 
ds double-stranded 
dsRBD double stranded RNA binding domain 
DUF domain of unknown function 
eiF eukaryotic initation factor 
endo-siRNA endogenous small interfering RNA 
ER endoplasmatic reticulum 
ES cells embryonic stem cells 
exo-siRNA exogenous small interfering RNA 
FH Flag-HA 
hcRNA heterochromatic RNAs 
IRES internal ribosomal entry site 
Loqs Loquatious 
miRNA microRNA 
miRNP micro ribonucleoprotein 
mRNP messenger Ribonucleoprotein 
NatsiRNA natural antisense-transcript small interfering RNA 
ncRNA non-coding RNA 
nt nucleotides 
p-bodies processing bodies 
Pol polymerase 
pre-miRNA precursor microRNA 
pri-miRNA primary microRNA 
rasiRNA repeat-assocaited small interfering RNA 
RdRP RNA dependent RNA polymerase 
RIIID RNAse III domain 
RISC RNA induced silencing complex 
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RITS RNA induced transcriptional gene silencing 
RNAi RNA Interference 
RNP ribonucleoprotein 
rRNA ribosomal RNA 
siRNA small interfering RNA 
snoRNA small nucleolar RNA 
snRNA small nuclear RNA 
ss single-stranded 
stRNA small temporal RNA 
tasi RNA trans-acting small interfering RNA 
tRNA transfer RNA 
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MiRNAs associated with human Ago1 and Ago2 (454 Sequencing) 
 read numbers % of total annotated reads % of total mirna reads 
miRNA Ago1 Ago2 Ago1 Ago2 Ago1 Ago2 
hsa-miR-17 4702 6698 26.41 20.95 28.28 21.46 
hsa-miR-106a 1508 500 8.47 1.56 9.07 1.60 
hsa-miR-25 1183 471 6.64 1.47 7.11 1.51 
hsa-miR-106b 1084 920 6.09 2.88 6.52 2.95 
hsa-miR-15b 857 593 4.81 1.85 5.15 1.90 
hsa-miR-151-5p 832 427 4.67 1.34 5.00 1.37 
hsa-miR-20a 729 7486 4.09 23.41 4.38 23.98 
hsa-miR-92a 646 2547 3.63 7.97 3.89 8.16 
hsa-miR-103 523 329 2.94 1.03 3.15 1.05 
hsa-miR-16 502 2402 2.82 7.51 3.02 7.70 
hsa-miR-221 364 244 2.04 0.76 2.19 0.78 
hsa-miR-93 278 1004 1.56 3.14 1.67 3.22 
hsa-miR-23b 273 129 1.53 0.40 1.64 0.41 
hsa-miR-15a 226 581 1.27 1.82 1.36 1.86 
hsa-miR-26b 223 179 1.25 0.56 1.34 0.57 
hsa-miR-27b 222 256 1.25 0.80 1.34 0.82 
hsa-miR-222 159 137 0.89 0.43 0.96 0.44 
hsa-miR-128 147 145 0.83 0.45 0.88 0.46 
hsa-miR-191 140 177 0.79 0.55 0.84 0.57 
hsa-miR-23a 138 77 0.78 0.24 0.83 0.25 
hsa-miR-652 128 76 0.72 0.24 0.77 0.24 
hsa-miR-196a 122 146 0.69 0.46 0.73 0.47 
hsa-miR-320 100 379 0.56 1.19 0.60 1.21 
hsa-miR-378 87 72 0.49 0.23 0.52 0.23 
hsa-miR-424 78 272 0.44 0.85 0.47 0.87 
hsa-miR-218 74 322 0.42 1.01 0.45 1.03 
hsa-miR-615-3p 62 26 0.35 0.08 0.37 0.08 
hsa-miR-27a 60 133 0.34 0.42 0.36 0.43 
hsa-miR-30estar 58 19 0.33 0.06 0.35 0.06 
hsa-miR-361-5p 57 95 0.32 0.30 0.34 0.30 
hsa-miR-152 49 9 0.28 0.03 0.29 0.03 
hsa-miR-17star 43 25 0.24 0.08 0.26 0.08 
hsa-miR-532-3p 34 35 0.19 0.11 0.20 0.11 
hsa-miR-532-5p 30 22 0.17 0.07 0.18 0.07 
hsa-miR-19b 30 360 0.17 1.13 0.18 1.15 
hsa-miR-151-3p 28 22 0.16 0.07 0.17 0.07 
hsa-miR-455-3p 28 12 0.16 0.04 0.17 0.04 
hsa-miR-185 27 61 0.15 0.19 0.16 0.20 
hsa-miR-26a 26 119 0.15 0.37 0.16 0.38 
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hsa-miR-374b 23 60 0.13 0.19 0.14 0.19 
hsa-miR-183 23 33 0.13 0.10 0.14 0.11 
hsa-miR-182 22 60 0.12 0.19 0.13 0.19 
hsa-miR-30c 22 126 0.12 0.39 0.13 0.40 
hsa-miR-766 21 18 0.12 0.06 0.13 0.06 
hsa-miR-942 21 30 0.12 0.09 0.13 0.10 
hsa-miR-30b 19 106 0.11 0.33 0.11 0.34 
hsa-miR-30astar 19 9 0.11 0.03 0.11 0.03 
hsa-miR-195 18 26 0.10 0.08 0.11 0.08 
hsa-miR-18a 18 799 0.10 2.50 0.11 2.56 
hsa-miR-877 16 4 0.09 0.01 0.10 0.01 
hsa-miR-1226 16 12 0.09 0.04 0.10 0.04 
hsa-miR-345 14 13 0.08 0.04 0.08 0.04 
hsa-miR-425 13 96 0.07 0.30 0.08 0.31 
hsa-miR-423-5p 13 19 0.07 0.06 0.08 0.06 
hsa-miR-24 12 32 0.07 0.10 0.07 0.10 
hsa-miR-148a 12 30 0.07 0.09 0.07 0.10 
hsa-miR-34a 12 27 0.07 0.08 0.07 0.09 
hsa-miR-196b 11 41 0.06 0.13 0.07 0.13 
hsa-miR-125b 10 7 0.06 0.02 0.06 0.02 
hsa-miR-22star 10 7 0.06 0.02 0.06 0.02 
hsa-miR-30d 10 59 0.06 0.18 0.06 0.19 
hsa-miR-7-1star 10 19 0.06 0.06 0.06 0.06 
hsa-miR-194 10 14 0.06 0.04 0.06 0.04 
hsa-miR-132 10 32 0.06 0.10 0.06 0.10 
hsa-miR-92b 9 23 0.05 0.07 0.05 0.07 
hsa-miR-99b 9 51 0.05 0.16 0.05 0.16 
hsa-miR-197 9 18 0.05 0.06 0.05 0.06 
hsa-miR-199b-3p 9 2 0.05 0.01 0.05 0.01 
hsa-miR-423-3p 9 74 0.05 0.23 0.05 0.24 
hsa-miR-221star 9 5 0.05 0.02 0.05 0.02 
hsa-miR-744 9 10 0.05 0.03 0.05 0.03 
hsa-miR-130b 8 18 0.04 0.06 0.05 0.06 
hsa-miR-503 8 37 0.04 0.12 0.05 0.12 
hsa-miR-378star 8 21 0.04 0.07 0.05 0.07 
hsa-miR-187 7 10 0.04 0.03 0.04 0.03 
hsa-miR-454 7 26 0.04 0.08 0.04 0.08 
hsa-miR-9 7 26 0.04 0.08 0.04 0.08 
hsa-miR-186 7 65 0.04 0.20 0.04 0.21 
hsa-miR-125a-5p 7 20 0.04 0.06 0.04 0.06 
hsa-miR-324-3p 7 51 0.04 0.16 0.04 0.16 
hsa-miR-497 7 3 0.04 0.01 0.04 0.01 
hsa-miR-590-3p 7 126 0.04 0.39 0.04 0.40 
hsa-miR-22 6 34 0.03 0.11 0.04 0.11 
hsa-miR-210 6 0 0.03 0.00 0.04 0.00 
hsa-miR-598 6 20 0.03 0.06 0.04 0.06 
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hsa-miR-107 6 1 0.03 0.00 0.04 0.00 
hsa-miR-501-3p 6 4 0.03 0.01 0.04 0.01 
hsa-miR-18astar 6 10 0.03 0.03 0.04 0.03 
hsa-miR-30e 6 53 0.03 0.17 0.04 0.17 
hsa-miR-7 5 46 0.03 0.14 0.03 0.15 
hsa-miR-126 5 20 0.03 0.06 0.03 0.06 
hsa-miR-181b 5 8 0.03 0.03 0.03 0.03 
hsa-miR-365 5 27 0.03 0.08 0.03 0.09 
hsa-miR-10a 5 65 0.03 0.20 0.03 0.21 
hsa-miR-212 5 10 0.03 0.03 0.03 0.03 
hsa-miR-96 5 8 0.03 0.03 0.03 0.03 
hsa-miR-28-3p 5 13 0.03 0.04 0.03 0.04 
hsa-miR-502-3p 4 2 0.02 0.01 0.02 0.01 
hsa-miR-340star 4 13 0.02 0.04 0.02 0.04 
hsa-miR-21 4 112 0.02 0.35 0.02 0.36 
hsa-miR-421 4 39 0.02 0.12 0.02 0.12 
hsa-miR-101 4 32 0.02 0.10 0.02 0.10 
hsa-miR-148b 4 12 0.02 0.04 0.02 0.04 
hsa-miR-484 4 74 0.02 0.23 0.02 0.24 
hsa-miR-301a 4 10 0.02 0.03 0.02 0.03 
hsa-miR-760 4 0 0.02 0.00 0.02 0.00 
hsa-miR-342-3p 3 49 0.02 0.15 0.02 0.16 
hsa-miR-122 3 0 0.02 0.00 0.02 0.00 
hsa-miR-19a 3 72 0.02 0.23 0.02 0.23 
hsa-miR-200c 3 8 0.02 0.03 0.02 0.03 
hsa-miR-877star 3 0 0.02 0.00 0.02 0.00 
hsa-miR-140-3p 3 31 0.02 0.10 0.02 0.10 
hsa-miR-330-3p 3 1 0.02 0.00 0.02 0.00 
hsa-miR-16-2star 3 19 0.02 0.06 0.02 0.06 
hsa-miR-624star 3 10 0.02 0.03 0.02 0.03 
hsa-miR-215 3 1 0.02 0.00 0.02 0.00 
hsa-miR-10b 2 26 0.01 0.08 0.01 0.08 
hsa-miR-486-5p 2 1 0.01 0.00 0.01 0.00 
hsa-miR-582-5p 2 4 0.01 0.01 0.01 0.01 
hsa-miR-29a 2 42 0.01 0.13 0.01 0.13 
hsa-miR-192 2 4 0.01 0.01 0.01 0.01 
hsa-miR-500star 2 2 0.01 0.01 0.01 0.01 
hsa-miR-9star 2 25 0.01 0.08 0.01 0.08 
hsa-miR-331-3p 2 3 0.01 0.01 0.01 0.01 
hsa-miR-374a 2 54 0.01 0.17 0.01 0.17 
hsa-miR-629 2 2 0.01 0.01 0.01 0.01 
hsa-miR-30dstar 2 0 0.01 0.00 0.01 0.00 
hsa-miR-425star 2 4 0.01 0.01 0.01 0.01 
hsa-miR-93star 2 2 0.01 0.01 0.01 0.01 
hsa-miR-362-5p 2 8 0.01 0.03 0.01 0.03 
hsa-miR-31 2 12 0.01 0.04 0.01 0.04 
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hsa-miR-629star 2 1 0.01 0.00 0.01 0.00 
hsa-miR-328 2 1 0.01 0.00 0.01 0.00 
hsa-miR-139-5p 2 2 0.01 0.01 0.01 0.01 
hsa-miR-486-3p 2 3 0.01 0.01 0.01 0.01 
hsa-miR-28-5p 2 20 0.01 0.06 0.01 0.06 
hsa-miR-190 2 8 0.01 0.03 0.01 0.03 
hsa-miR-505 2 5 0.01 0.02 0.01 0.02 
hsa-miR-548c-5p 2 7 0.01 0.02 0.01 0.02 
hsa-miR-140-5p 1 3 0.01 0.01 0.01 0.01 
hsa-miR-146a 1 0 0.01 0.00 0.01 0.00 
hsa-miR-200b 1 1 0.01 0.00 0.01 0.00 
hsa-miR-25star 1 0 0.01 0.00 0.01 0.00 
hsa-miR-455-5p 1 2 0.01 0.01 0.01 0.01 
hsa-miR-483-5p 1 0 0.01 0.00 0.01 0.00 
hsa-miR-32 1 5 0.01 0.02 0.01 0.02 
hsa-miR-642 1 0 0.01 0.00 0.01 0.00 
hsa-miR-657 1 0 0.01 0.00 0.01 0.00 
hsa-miR-339-5p 1 4 0.01 0.01 0.01 0.01 
hsa-miR-339-3p 1 6 0.01 0.02 0.01 0.02 
hsa-miR-542-3p 1 0 0.01 0.00 0.01 0.00 
hsa-miR-181a-2star 1 3 0.01 0.01 0.01 0.01 
hsa-miR-625 1 1 0.01 0.00 0.01 0.00 
hsa-miR-324-5p 1 7 0.01 0.02 0.01 0.02 
hsa-miR-550star 1 1 0.01 0.00 0.01 0.00 
hsa-miR-181a 1 7 0.01 0.02 0.01 0.02 
hsa-miR-410 1 0 0.01 0.00 0.01 0.00 
hsa-miR-204 1 1 0.01 0.00 0.01 0.00 
hsa-miR-106bstar 1 2 0.01 0.01 0.01 0.01 
hsa-miR-504 1 0 0.01 0.00 0.01 0.00 
hsa-miR-708 1 4 0.01 0.01 0.01 0.01 
hsa-miR-590-5p 1 13 0.01 0.04 0.01 0.04 
hsa-miR-30a 1 18 0.01 0.06 0.01 0.06 
hsa-miR-222star 1 1 0.01 0.00 0.01 0.00 
hsa-miR-193b 1 2 0.01 0.01 0.01 0.01 
hsa-miR-548b-5p 1 1 0.01 0.00 0.01 0.00 
hsa-miR-374astar 1 4 0.01 0.01 0.01 0.01 
hsa-miR-338-3p 1 0 0.01 0.00 0.01 0.00 
hsa-miR-874 1 0 0.01 0.00 0.01 0.00 
hsa-miR-362-3p 1 18 0.01 0.06 0.01 0.06 
hsa-miR-340 1 12 0.01 0.04 0.01 0.04 
hsa-miR-15bstar 1 4 0.01 0.01 0.01 0.01 
hsa-miR-10astar 1 6 0.01 0.02 0.01 0.02 
hsa-miR-369-3p 1 0 0.01 0.00 0.01 0.00 
hsa-miR-296-3p 1 1 0.01 0.00 0.01 0.00 
hsa-miR-330-5p 1 0 0.01 0.00 0.01 0.00 
hsa-miR-450a 1 17 0.01 0.05 0.01 0.05 
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hsa-miR-628-3p 1 1 0.01 0.00 0.01 0.00 
hsa-miR-346 1 0 0.01 0.00 0.01 0.00 
hsa-miR-98 1 0 0.01 0.00 0.01 0.00 
hsa-miR-361-3p 1 6 0.01 0.02 0.01 0.02 
hsa-miR-126star 1 11 0.01 0.03 0.01 0.04 
hsa-miR-199b-5p 1 1 0.01 0.00 0.01 0.00 
hsa-miR-589 1 0 0.01 0.00 0.01 0.00 
hsa-miR-34c-3p 1 0 0.01 0.00 0.01 0.00 
hsa-miR-95 1 1 0.01 0.00 0.01 0.00 
hsa-miR-190b 1 0 0.01 0.00 0.01 0.00 
hsa-miR-29b 1 8 0.01 0.03 0.01 0.03 
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